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Addiction is a chronic relapsing brain disorder, which is classified as major social, legal and 
public health problem. Substance use disorders have been postulated to be associated with 
alterations of neural networks related to reward processing, motivation, memory, and 
behavioral control, leading to compulsive drug use. Consequently, the value of the abused 
drug is proposed to be increased, while the value of other (natural) reinforcers is decreased in 
addiction. However, it is not known, whether neuroadaptations are persistent or reversible 
after longer periods of abstinence. Furthermore, it is unclear if already recreational drug use is 
associated with lasting alterations in neurotransmission and whether these alterations are 
related to deficits in social cognition and interaction. As these issues are important to develop 
more effective prevention as well as treatment and after-care strategies, we assessed drug cue 
reactivity in current and long-term abstinent heroin users (Chapter 2), and sensorimotor gating 
and social cognition in recreational and dependent cocaine user (Chapters 3 and 4). Both 
heroin and cocaine have been classified as the two drugs bearing the highest harm, with a 
substantial tendency to induce dependence, and physical as well as social harm. Due to this 
strong impact on health and society, the following experimental studies were conducted with 
heroin and cocaine users.  
The studies presented in Chapter 2 aimed at investigating implicit and explicit valence of drug 
cues in heroin users at different stages of abstinence using affective startle modulation 
(implicit) and valence ratings (explicit). Although drug induced neuroadaptations in brain 
circuits related to memory have been proposed to be long-lasting, it is unknown whether 
appetitive effects of heroin-related cues persist after prolonged abstinence. Fifteen current 
heroin users were measured before and after detoxification therapy. Correspondingly, 15 
healthy control participants were tested twice at the same interval of 14 days. Fourteen long-
term abstinent heroin users (abstinence duration > 1 year) were assessed additionally. After 
detoxification and even after prolonged abstinence, heroin cues still exert implicit appetitive 
effects in heroin users. This confirms that drug-induced adaptations of reward and memory 
circuits are long-lasting, resulting in a highly stable addiction memory, and therefore an 
increased susceptibility to relapse. 
In the second study (Chapter 3), we investigated if already recreational drug use is associated 
with alterations in neurotransmission, measured with prepulse inhibition (PPI) of the acoustic 





startle response. PPI is a measure of early information processing, more precisely sensorimotor 
gating, and highly sensitive for manipulations of the catecholamine system. Therefore, we 
assessed PPI in 64 recreational cocaine users, 29 dependent cocaine users and 66 stimulant-
naïve control subjects. Moreover, the influences of craving and attention-deficit/hyperactivity 
disorder (ADHD) symptoms on PPI were examined, as ADHD is highly comorbid with cocaine 
use. Recreational and dependent cocaine users showed increased PPI in comparison with 
control subjects. This increase in PPI was correlated with duration and amount of cocaine use. 
Moreover, users with a diagnosis of ADHD and strong craving symptoms displayed the highest 
increases in PPI levels. This suggests that alterations of early information processing, 
presumably reflecting changes in catecholamine signaling do not only occur after the 
development of cocaine addiction but already in a non-addicted state. Furthermore, ADHD 
might be a critical risk factor for cocaine-induced neurochemical plasticity. In addition, PPI 
might provide a noninvasive and accessible measure to objectively capture craving symptoms.  
The study presented in Chapter 4 aimed to investigate potential alterations in social 
cognition and real-life social functioning in cocaine users. Social abilities are particularly 
important as social cognition and real-life social behavior have a strong impact on treatment 
success in psychiatric disorders. Furthermore, pharmacological treatments for cocaine 
addiction are currently lacking and cognitive-behavioral therapeutic approaches rely, at least in 
part, on the emotional responsiveness of the patients. To determine social cognitive abilities in 
cocaine users, we investigated 69 recreational cocaine users, 31 dependent cocaine users, and 
68 stimulant-naïve controls by means of video-based and photorealistic tests and related these 
measures to real-life indicators of social functioning. Our results suggest that recreational and 
dependent cocaine use is associated with deficits in emotional empathy, whereas dependent 
cocaine users additionally show impairments in mentalizing. These social cognition deficits are 
related to real-life social behavior such as a smaller social network and more criminal offences. 
Furthermore, a younger age of cocaine use onset was linked to pronounced deficits in 
empathy. These deficits have to be considered to improve the outcomes of therapies. 
Taken together, these results indicate that neuroadaptations induced by substance use 
are long-lasting and therefore trigger relapse even after prolonged abstinence. Moreover, 
alterations in neurotransmission may already occur in a non-addicted state of drug use. ADHD 
symptoms might influence the vulnerability for drug-induced plasticity, at least in stimulant 
users. Furthermore, drug use is associated with deficits in social cognition and social behavior, 
in particular if drug use already occurred at an early age. The general discussion of this thesis 





provides a review of the main results. Considerations regarding the implications for models of 
addiction, clinical practice and future research are discussed.  







Substanzabhängigkeit ist eine chronische neurologische Krankheit, die häufig zu Rückfällen 
führt. Sie wurde als ernstes gesellschaftliches und juristisches Problem eingestuft, das eine 
grosse Belastung für das Gesundheitswesen darstellt. Substanzabhängigkeit wird mit 
Veränderungen neuronaler Netzwerke in Verbindung gebracht, die an 
Belohnungsverarbeitung, Motivation, Gedächtnis und Verhaltenskontrolle beteiligt sind. Diese 
neuronalen Adaptationsprozesse unterstützen vermutlich den zwanghaften Substanzkonsum. 
In Folge dessen kann der Wert der Substanz überhöht verarbeitet werden, während andere 
(natürliche) Verstärker unterbewertet werden können. Allerdings ist nicht bekannt, ob diese 
neuroadaptiven Veränderungen bestehen bleiben, oder nach längerer Abstinenz reversibel 
sind. Ausserdem ist unklar, ob schon gelegentlicher Substanzkonsum mit langfristigen 
Veränderungen der Neurotransmission assoziiert ist, und ob diese Veränderungen mit 
Defiziten in der sozialen Kognition einher gehen. Die Beantwortung dieser Fragen ist essentiell, 
um effektivere Präventions-, Behandlungs-, und Nachsorge-Methoden zu entwickeln. Deshalb 
untersuchten wir die Verarbeitung von Drogenhinweisreizen bei aktuellen und Langzeit-
abstinenten Heroinkonsumenten (Kapitel 2), und sensomotorische Filterfunktionen 
(„sensorimotorisches Gating“) und soziale Kognition bei Gelegenheits- und abhängigen 
Kokainkonsumenten (Kapitel 3 und 4). Heroin und Kokain wurden als die zwei illegalen Drogen 
mit dem grössten Schädigungsrisiko eingestuft, da sie ein hohes Abhängigkeitspotential 
aufweisen, und ein grosses Ausmass an physischem sowie sozialem Leid auslösen können. 
Wegen dieses grossen Einflusses auf individuelle Gesundheit und Gesellschaft, wurden die 
folgenden experimentellen Studien mit Heroin- und Kokainkonsumenten durchgeführt.  
Die Studien, die in Kapitel 2 vorgestellt werden, untersuchen die implizite und explizite Valenz 
von Drogenreizen mittels affektiver Schreckreflexmodulation (implizit) und Valenz-
Bewertungen (explizit) bei Heroinkonsumenten in verschiedenen Phasen der Abstinenz. Auch 
wenn angenommen wird, dass neuroadaptive Veränderungen in Folge des Drogenkonsums in 
den Gedächtnissystemen des Gehirns dauerhaft sind, ist bisher unbekannt, ob 
Heroinhinweisreize auch nach anhaltender Abstinenz noch appetitive Reaktionen auslösen 
können. Fünfzehn Heroinkonsumenten wurden vor und nach der Entzugsbehandlung 
untersucht. Ausserdem nahmen 15 gesunde Kontrollprobanden im gleichen Abstand von 14 
Tagen an der Untersuchung teil. Vierzehn langzeitig abstinente Heroinkonsumenten 





(Abstinentdauer > 1 Jahr) wurden zusätzlich untersucht. Nach der Entzugsbehandlung und 
sogar nach anhaltender Abstinenz hatten Heroinhinweisreize immer noch appetitive Effekte 
für Heroinkonsumenten. Dies zeigt, dass substanzinduzierte adaptive Veränderungen des 
Belohnungs- und Gedächtnissystems langanhaltend sein können, und zu einem stabilen 
Drogengedächtnis und damit einer anhaltenden Vulnerabilität für Rückfälle führen. 
In der zweiten Studie (Kapitel 3) wurde untersucht, ob schon gelegentlicher Substanzkonsum 
mit Veränderungen der Neurotransmission verbunden ist. Dies wurde mittels der 
Präpulsinhibition (PPI) des akustischen Schreckreflexes gemessen. Die PPI ist ein Mass der 
frühen Informationsverarbeitung, spezifischer des sensomotorischen Gatings, welches äusserst 
sensitiv für Manipulationen am Katecholamin-System ist. Entsprechend erhoben wir die PPI bei 
64 gelegentlichen Kokainkonsumenten, 29 abhängigen Kokainkonsumenten und 66 Kontrollen 
ohne Stimulanzienkonsum. Ausserdem wurde der Einfluss von „Craving“ (Verlangen nach der 
Droge) und von Symptomen der Aufmerksamkeits-Defizit/Hyperaktivitätstörung (ADHS) auf 
die PPI untersucht, da ADHS sehr häuftig komorbid mit Kokainkonsum auftritt. Gelegentliche 
und abhängige Kokainkonsumenten zeigten im Vergleich zur Kontrollgruppe eine erhöhte PPI. 
Diese Erhöhung war mit der Dauer und der Menge des Kokainkonsums korreliert. Des 
Weiteren zeigten Kokainkonsumenten mit einer ADHS Diagnose und Craving-Symptomen die 
stärkste Erhöhung des PPI-Niveaus. Dies könnte zeigen, dass Veränderungen der frühen 
Informationsverarbeitung, die vermutlich Änderungen der Katecholamin-Neurotransmission 
abbilden, nicht nur auftreten, nachdem sich eine Abhängigkeit von Kokain entwickelt hat, 
sondern schon in einem nicht-abhängigen Zustand vorhanden sind. Ausserdem könnten ADHS-
Symptome eine wichtige Rolle als Risikofaktor für Kokain-induzierte neurochemische Plastizität 
spielen. Zusätzlich könnte die PPI ein non-invasives und gut zugängliches Mass für die objektive 
Messung von Craving-Symptomen darstellen.  
Die Studie, die in Kapitel 4 präsentiert wird, untersucht potentielle Veränderungen der sozialen 
Kognition und das soziale Funktionieren im Alltagsleben von Kokainkonsumenten. Soziale 
Fähigkeiten sind besonders wichtig, da sich gezeigt hat, dass soziale Kognition und das soziale 
Verhalten im Alltag einen starken Einfluss auf den Behandlungserfolg bei psychiatrischen 
Krankheiten haben. Des Weiteren fehlen bisher effiziente pharmakologische 
Behandlungsmöglichkeiten der Kokainabhängigkeit und verhaltenstherapeutische 
Behandlungsmethoden sind, wenigstens zum Teil, auf die emotionale Ansprechbarkeit des 
Patienten angewiesen. Um sozial-kognitive Fähigkeiten in Kokainkonsumenten zu bestimmen, 
untersuchten wir 69 gelegentliche Kokainkonsumenten, 31 abhängige Kokainkonsumenten 





und 68 Kontrollprobanden mit videobasierten und fotorealistischen Tests und korrelierten 
diese Masse mit Indikatoren des sozialen Funktionsniveaus im Alltag. Unsere Ergebnisse lassen 
vermuten, dass gelegentlicher und abhängiger Kokainkonsum mit Defiziten in emotionaler 
Empathie assoziiert ist. Abhängige Kokainkonsumenten zeigen ausserdem zusätzliche Defizite 
der mentalen Perspektivenübernahme („Mentalizing“). Diese Defizite der sozialen Kognition 
waren assoziiert mit dem sozialen Verhalten im Alltagsleben, wie einem kleineren sozialen 
Netzwerk und mehr begangenen Straftaten. Des Weiteren konnte gezeigt werden, dass der 
Beginn von Kokainkonsum in jüngeren Jahren mit grösseren Defiziten der Empathie verbunden 
ist. Diese Einschränkungen sollten in Betracht gezogen werden, um den Erfolg von Therapien 
zu verbessern.  
Zusammengefasst legen diese Ergebnisse nahe, dass neuroadaptive Veränderungen durch 
Substanzkonsum langanhaltend sind und entsprechend selbst nach längerer Abstinenzzeit 
einen Rückfall auslösen könnten. Ausserdem können Veränderungen der Neurotransmission 
schon bei nicht-abhängigen Konsumenten auftreten. ADHS-Symptome könnten des Weiteren 
die Vulnerabilität für Substanz-induzierte Plastizität bei Stimulanzienkonsumenten erhöhen. 
Darüber hinaus ist Substanzkonsum mit Defiziten der sozialen Kognition und des sozialen 
Verhaltens verbunden, vor allem, wenn Drogen schon in jungen Jahren konsumiert wurden. 
Der Diskussionsteil dieser Arbeit liefert eine Zusammenfassung der Hauptergebnisse. 
Weiterhin werden Implikationen für Abhängigkeitsmodelle, klinische Arbeit und zukünftige 
Forschung diskutiert.  


























1.1 Substance use disorders and the brain 
 
Drug dependence is a chronic relapsing brain disorder (Hser et al., 2001) which is defined by 
compulsive and uncontrolled drug use. Despite serious negative consequences like illness, 
disrupted social relationships, and the loss of employment, an addicted person’s life is 
centered around the drug of choice and activities related to it (Hyman and Malenka, 2001; 
Madsen et al., 2012). Many case reports describe people who suffered from life-threatening 
clinical conditions, depression, utter financial ruin, and social isolation due to drug use but still 
were not able to quit (Hyman and Malenka, 2001; Volkow et al., 2011a; Waldorf et al., 1991). 
Furthermore, drug dependence is associated with an enduring, maybe life-long, susceptibility 
to relapse, often triggered by cues related to the formerly abused drug (Hyman and Malenka, 
2001; O'Brien, 1997; Wise and Bozarth, 1987). It is estimated that 22.6 million people in the 
USA (8.9% of the population) are active (use within the month preceding the survey) illicit drug 
users (SAMHSA, 2011). In Europe, at least 1.1 million people received treatment for illicit drug 
use in 2010 (EMCDDA, 2012). Four percent of all deaths of Europeans aged 15-39 are reported 
to be drug-induced (EMCDDA,2012). Expressed in economic terms, the costs of drug abuse are 
estimated at 180.9 billion dollars in the USA (Office of National Drug Control Policy, 2004). 
Therefore, drug misuse and abuse are classified as a major social, legal, and public-health 
problems (Nutt et al., 2007).  
Volkow et al. (2011a; 2003; 2011b) proposed a model of the addicted human brain, in order to 
explain loss of control and compulsive drug intake. According to this model, four brain circuits 
are engaged in drug abuse and addiction and undergo neuroadaptations with repeated drug 
use: 1) nucleus accumbens (NAc) and ventral pallidum: reward; 2) orbitofrontal cortex (OFC): 
motivation/drive; 3) amygdala and hippocampus: memory and learning; 4) prefrontal cortex 
(PFC) and anterior cingulated gyrus: control (Volkow et al., 2003). These four circuits influence 
the decisions a person makes by assigning the momentary salience or expected reward to 
behavioral alternatives. Memories of previous exposures to the situation or the stimulus and 
internal needs or drives (e.g., hunger or craving) influence the assigned value. Cognitive 
control engages in the decision to act or not to act. In addiction, the value of the abused drug 
is proposed to be increased, while the value of other (natural) reinforcers is decreased. This 
shift might be caused by the higher rewarding properties of drugs: Acute drug administration is 
associated with 3- to 5- fold higher NAc dopamine (DA) levels than conventional rewards 




(Volkow et al., 2003; Wise, 2002)
this weakens the inhibitory control by the PFC and results in a positive
to compulsive drug taking 
addicted drug use (Madsen 
Figure 1.  Model by Volkow 
contributing to addiction: reward, motivation/drive, memory/c
addicted brain, the value of the drug of choice is enhanced in reward, motivation and 
memory circuits. This overcomes the inhibitory control of the PFC and triggers a positive
feedback loop leading to compulsive drug use. S
theses neurodaptations: dopamine, glutamate, GABA, norepinephrine, corticotrophic 
releasing factor, and opioid receptors. Adapted from Volkow 
 
This model is in line with theories of addiction memory, which presume 
between neuroplasticity, learning, memory, and drug addiction 
Hyman and Malenka, 2001; Hyman 
1996). Neural networks engaged in plasticity and consolidation of experiences (dopaminergic 
and glutamatergic systems) are suggested to be influenced by repeated drug administration 
and drug-context pairings 
 
. Together with overactive motivation and memory circuits, 
-feedback loop leading 
(Volkow et al., 2003) and the transition from recreational to 
et al., 2012) (Figure 1).  
et al. (2011a; 2003; 2011b) suggesting a network of four brain circuits 
onditioning, and control. In the 
everal neurotransmitters are involved in 
et al. (2011a; 2003; 2011b)
(Berke and Hyman, 2000; 
et al., 2006; Kelley, 2004; Robbins and Everitt, 2002; White, 












theory of addiction (Robinson and Berridge, 1993) suggests that avoidance of withdrawal 
symptoms is not the most important factor in the maintenance of drug use as proposed by 
negative reinforcement theories (Solomon and Corbit, 1974; Tiffany, 1990). Neuroadaptations 
resulting from repeated drug use are suggested to render the DA system hypersensitive 
(sensitized) to drugs and drug-associated stimuli. This sensitization turns the act of drug taking 
and drug cues into potent incentives which induce a strong feeling of wanting to use the drug 
(“craving”). Previous studies have provided support for this model by showing that drug 
associated cues are processed as appetitive by dependent smokers (Dempsey et al., 2007; 
Geier et al., 2000) and alcohol users (Mucha et al., 2000).  
Furthermore, this model has implications for social cognition in addicted persons. Sensitivity to 
social reinforcers such as social interaction might be reduced, while the value of the drug of 
choice is increased (Volkow et al., 2003). Moreover, neural networks described to be affected 
by drug use (e.g., frontal areas and the DA system) also engaged in social cognition and social 
reward (Abu-Akel and Shamay-Tsoory, 2011; Fan et al., 2012; Gallagher and Frith, 2003; Krach 
et al., 2010). This may have a negative impact on general social competence and might explain 
why social threats such as imprisonment or familial problems may fail to detain drug addicted 
people from using the drug (Volkow et al., 2011a; 2003; 2011b). 
However, some open questions remain, which we aim to address in the experimental studies 
of this thesis (Chapters 2-4): Firstly, although drug induced neuroadaptations in brain circuits 
related to memory have been proposed to be long-lasting, it is unknown whether appetitive 
effects of heroin-related cues are stable after prolonged abstinence. Therefore, the studies 
presented in Chapter 2 investigate the implicit valence of drug-related stimuli in different 
states of abstinence in current and former heroin addicted patients. Secondly, it is not clear if 
recreational drug use is already associated with alterations in neurotransmission. In Chapter 3, 
we therefore investigated if alterations in sensorimotor gating - associated with catecholamine 
neurotransmission - can already be measured in a non-addicted state of cocaine use. Thirdly, it 
is not known, if social cognition deficits predicted by the model by Volkow et al. (2011a; 2003; 
2011b) are existent and can be measured in cocaine users. Thus, in Chapter 4, we studied 
social cognition in recreational and dependent cocaine users and investigated if potential 
deficits are related to real-life social functioning.   




1.2 Heroin and cocaine use 
 
In the previous paragraph, it was described that the aim of this thesis is to gain more insight 
into the neural, behavioral and social alterations which might accompany drug use in different 
states of addiction (non-dependent use, dependence, and abstinence). This knowledge may 
help to improve prevention, treatment and after-treatment strategies. Heroin and cocaine 
have been classified as the two drugs with the highest harm score, when physical harm, the 
tendency to induce dependence, and social harm (the effect of drug use on families, 
communities, and society) are factored into the rating (Nutt et al., 2007). Due to this strong 
impact on health and society, the experimental part of this thesis (Chapter 2-4) focuses on 
users of heroin and cocaine. In the following paragraphs, heroin and cocaine use (1.2.1), their 
acute effects and mode of action (1.2.2), and neuroadaptive changes associated with 
dependent use (1.2.2 and 1.2.4) will be further discussed. In Chapter 1.3 methodical 
considerations related to the experimental studies of this thesis (Chapters 2-4) will be 
explained. After that, the study samples of Chapter 2 and the Zurich Cocaine Cognition Study 
(ZuCo²St), which incorporates the studies presented in Chapter 3 and 4, will be introduced.  
 
1.2.1 Prevalence of heroin and cocaine use 
The use of heroin has been stable from 2005 to 2010 (EMCDDA, 2012). 1.4 million problem 
opioid users were reported in the European Union and Norway in 2010 (EMCDDA, 2012). More 
than half of treatment seeking drug users report opioides as their primary drug in Europe. 
Furthermore, heroin is responsible for the greatest part of morbidity and mortality related to 
drug use in the European Union (EMCDDA, 2011).  
Cocaine is the second most prevalent illegal drug after cannabis in Europe (EMCDDA, 2011; 
2012) and the USA (HHS, 2011). Lifetime prevalence for cocaine use is estimated at 6.3% in 
Europe among 15 to 34 year olds (EMCDDA, 2012) and 13.3% in the USA among 18 to 25 year 
olds (SAMHSA, 2011). As not everyone exposed to drugs will undergo the transition to 
dependence (genetic, developmental and environmental factors also influence this transition 
(Volkow and Li, 2005)), recreational cocaine use is reported to be a prevalent consumption 
pattern (EMCDDA, 2011).  




1.2.2 Acute effects of heroin and cocaine 
The acute effects of heroin (diacetylmorphine) are ascribed to the stimulation of opioid 
receptors (mu, delta, and kappa) and the indirect increase of DA levels by reducing the 
inhibitory effect of GABA in the ventral tegmental area (Fernandez-Serrano et al., 2011; 
Johnson and North, 1992). Repeated use of heroin induces tolerance and physical dependence 
associated with severe withdrawal symptoms. Before tolerance is developed, acute heroin 
administration produces feelings of euphoria often referred to as “rush”, sedation, and 
tranquility (Cami and Farre, 2003). 
Acute administration of cocaine increases the synaptic levels of DA, serotonin, and 
norepinephrine (NE) via a blockade of the corresponding presynaptic transporters (Ritz et al., 
1990). The acute effect of cocaine leads to an intense feeling of euphoria (“high”), which is 
mainly associated with DA transporter (DAT) occupancy (Bolla and Cadet, 2007). Further 
effects of acute cocaine use are enhanced attention and sensory alertness (to light, sound and 
touch), accelerated thinking, increased self-confidence, and suppression of the need to eat or 
sleep (Brownlow and Pappachan, 2002). The phase of euphoria only lasts up to one hour, 
followed by a period of craving, depression, low energy, and impaired cognition (“crash”) if no 
more cocaine is administered (Gawin and Kleber, 1986). 
 
1.2.3 Neuroadaptive changes and cue reactivity in dependent heroin users 
Opiate-dependent patients have been reported to show alterations in brain areas which are 
part of the addiction networks proposed by Volkow et al. (2011a; 2003; 2011b). Studies using 
voxel-based morphometry (VBM) found reductions in gray matter in prefrontal, temporal, and 
cingulate cortices (Lyoo et al., 2006; Upadhyay et al., 2010; Wang et al., 2012). Using diffusion 
tensor imaging (DTI) altered white matter integrity in reward circuits and memory-related 
areas has been reported in heroin-dependent patients undergoing methadone maintenance 
treatment (Lin et al., 2012). Furthermore, altered white matter integrity was correlated with 
worse scores in memory function (Lin et al., 2012).  
Supporting theories of addiction memory (Berke and Hyman, 2000; Hyman and Malenka, 
2001; Hyman et al., 2006; Kelley, 2004; Robbins and Everitt, 2002; White, 1996), enhanced 
attentional processing of heroin cues has been reported for heroin dependent patients using 
methods like the Stroop task and electrodermal responses (Franken et al., 2000; Lubman et al., 




2008). This attentional bias has been associated with alterations in DA functioning (Franken et 
al., 2004). Enhanced cue reactivity has also been found to be a predictor for future heroin use 
and relapse after treatment (Fatseas et al., 2011; Lubman et al., 2009; Marissen et al., 2006). 
Therefore, sustained appetitive value of heroin cues might contribute to the high relapse rates 
in heroin addiction (Carter and Tiffany, 1999; Fatseas et al., 2011). However, so far, the implicit 
valence of drug-related cues has not been investigated in heroin users before and after 
detoxification and withdrawal therapy, and after long-term abstinence from opioids. 
Therefore, the study presented in Chapter 2 focuses on this issue. 
 
1.2.4 Neuroadaptive changes in dependent cocaine users and associations with behavior 
Chronic cocaine use has also been shown to be associated with neuroadaptations in brain 
areas which are part of the addiction networks proposed by Volkow et al. (2011a; 2003; 
Volkow et al., 2011b). In particular, structural and functional alterations have been reported in 
the frontal lobe, i.e. the orbitofrontal cortex (OFC) and the prefrontal cortex (PFC), the anterior 
cingulate cortex (ACC), temporal cortices including insula, and striatal regions of chronic 
cocaine users (Bolla et al., 2004; Ersche et al., 2011; Franklin et al., 2002; Hanlon and 
Canterberry, 2012; Kuhar and Pilotte, 1996; Makris et al., 2008; Volkow et al., 1992). It has 
been shown that a longer duration of cocaine use is associated with greater grey matter 
reductions in the OFC, ACC, and the insular cortex (Ersche et al., 2011). Previous studies also 
reported reduced cortical thickness for the dorsolateral prefrontal cortex (DLPFC) and 
temporal cortices in dependent cocaine users compared with controls (Franklin et al., 2002; 
Makris et al., 2008). Furthermore, less resting-state functional connectivity has been reported 
in frontolimbic systems in cocaine dependent subjects (Verdejo-Garcia et al., 2012). Using 
Positron Emission Tomography (PET), it has repeatedly been shown that chronic cocaine use is 
associated with reduced striatal DA D2 receptor availability and blunted striatal DA release 
(Martinez et al., 2004; Martinez et al., 2007; Volkow et al., 1993; Volkow et al., 1997b). These 
dysfunctions in the DA system of dependent cocaine users have been associated with 
extensive consequences including craving, impulsive behavior, loss of control over drug intake, 
and relapse (Martinez et al., 2007; Volkow et al., 1997a; Volkow et al., 1997b). Nevertheless, it 
has not been investigated yet, if these dysfunctions only occur in a cocaine-addicted state or if 
already recreational cocaine users show alterations in neurotransmission. Thus, the study 
presented in Chapter 3 aims to investigate this question. 




Furthermore, Volkow and Li (2004) suggested that adaptations reported in dopaminergic 
circuits turn cocaine users less sensitive to dopamine increases induced by natural reinforcers. 
Previous studies support this idea by reporting that cocaine users show reduced sensitivity to 
secondary reinforcers such as monetary reward (Goldstein et al., 2007a; 2007b). Additionally, 
dysfunction of the OFC of chronic cocaine users has been associated with impaired descision-
making abilities (Bolla et al., 2003). Moreover, altered functioning of the PFC and ACC have 
been related to deficits in impulse control (Bolla et al., 2004). These brain areas and functions 
have also been shown to play a role in social cognition (Abu-Akel and Shamay-Tsoory, 2011; 
Volkow et al., 2011a). However, studies on social cognition in cocaine users are scarce. 
Therefore, the data shown in Chapter 4 evaluate empathy, metalizing and real-life social 
functioning in cocaine users.  
 
  




1.3 Methodical considerations 
 
In the previous paragraphs, it was explained that the experimental part of this thesis is 
designed to examine presumed lasting changes in cue-reactivity after therapy and long-term 
abstinence, to explore if alterations in neurotransmission already occur in a non-addicted state 
of drug use, and if drug use is associated with changes in social functioning. In order to 
investigate these issues, we conducted the studies reported in detail in Chapters 2-4 using the 
following methods: Affective startle modulation (Chapter 2), prepulse inhibition (PPI), startle 
reactivity, and habituation (Chapter 3), and video- and photo-based behavioral tests of social 
cognition, in combination with real-life measures of social functioning (Chapter 4). These 
methods are briefly described in the following paragraphs.  
 
1.3.1 Affective startle modulation 
Affective startle modulation is a well-established non-subjective method to assess the implicit 
valence of stimuli and in particular drug-associated cues (Grillon and Baas, 2003). The acoustic 
startle reflex (ASR) is induced by a sudden and intense auditory environmental stimulus and is 
most reliably measured as a rapid closure of the eyelids. It occurs reflexively as a contraction of 
the orbicularis oculi muscle 30-50ms after the onset of the startling stimulus (Lang et al., 1990) 
and can be recorded using electromyography (EMG). A primary startle circuit regulates the ASR 
by a three-synapse pathway in the brainstem: Over the cochlear nerve startling input reaches 
the nucleus reticularis pontis caudalis (PnC) and is then sent to spinal motor neurons (Koch, 
1999). This eye-blink reflex provides an objective measure of a person’s affective reactions and 
motivational status towards stimuli, as there is a linear relationship between the affective 
valence of a foreground stimulus and startle magnitude: The reflex is inhibited when an 
individual is exposed to pleasant pictures and is augmented when the person views unpleasant 
pictures (Lang et al., 1990, 1998). This affective modulation of the startle reflex is ascribed to a 
motivational priming effect: The startling noise elicits a negative, defensive reflex, which 
probably serves a protective function, such as avoiding organ injury (Graham, 1975). Negative 
foreground stimuli activate the defense motive system and induce an emotional aversive state. 
This results in an augmentation of the defensive startle reflex. On the other hand, positive 




affective priming weakens the aversive state and therefore inhibits the startle reflex and 
reduces the startle magnitude (Lang et al., 1998).  
The affect-modulated startle method has been repeatedly used in addiction research. 
Photographs of drug paraphernalia or drug intake rituals are used as foreground stimuli and 
the suppression of the startle response by drug-related scenes relative to neutral scenes 
(referred to as cue-related startle suppression, CSS) is measured. In this context, objective 
measures are particularly important, as the reaction to drug-related cues might be in part 
unconscious (Tiffany and Drobes, 1990). In general, these studies confirmed incentive theories 
of drug addiction (discussed in Chapter 1.1). CSS and therefore appetitive effects of drug cues 
have been reported in addicted users of alcohol or nicotine while viewing drug-related cues 
(Cinciripini et al., 2006; Dempsey et al., 2007; Geier et al., 2000; Mucha et al., 2000). However, 
it is not known, whether heroin-related cues still elicit implicit appetitive effects after drug 
withdrawal and therapy and after long-term abstinence. Therefore, in the studies described in 
Chapter 2, affective startle modulation was used to assess implicit affective reactions in to 
heroin-related cues in addition to explicit ratings of valence and craving in 15 current heroin 
users before and after detoxification therapy, 14 long-term abstinent heroin users and 15 
controls. We hypothesized that heroin cues sustain their incentive value even after longer 
periods of therapy and abstinence. This would help to explain the high relapse rates in heroin 
users (O'Brien, 1997) and support addiction memory theories which propose long-lasting 
changes in the memory circuits of drug users.  
 
1.3.2 Prepulse inhibition 
PPI of the ASR is a form of startle plasticity, which is considered as a translational measure of 
sensorimotor gating. Sensorimotor gating describes an early information processing 
mechanism and a universal preattentional filter function by which irrelevant stimuli are gated 
out, so that a person can focus on the most important aspects of the environment (Braff and 
Geyer, 1990; Braff et al., 2001). PPI refers to the natural, unlearned attenuation of the startle 
response when the intense startling stimulus (pulse) is preceded by a weaker non-startling 
stimulus (prepulse) by 30 - 500 ms (Graham, 1975). PPI has been reported across a large 
variety of species: besides others in fish (Burgess and Granato, 2007), rodents (Hoffman and 
Searle, 1965), non-human primates (Linn and Javitt, 2001), and humans (Braff and Geyer, 




1990). In humans, ASR and PPI are measured by EMG of the orbicularis oculi facial muscle, as 
described in 1.3.1. 
PPI is regulated by sequential and parallel neural connections of a cortico-striato-pallido-
pontine (CSPP) circuit, which involves the PFC, the ventral striatum including the NAc, the 
ventral pallidum, and the ventral tegmentum (Koch, 1999; Swerdlow et al., 1999). This CSPP 
circuit converges with the primary startle circuit (see 1.3.1) at the PnC (Swerdlow et al., 1999). 
DA and NE have been shown to play a crucial role in the regulation of PPI (Alsene et al., 2011; 
Zhang et al., 2000). Consequently, PPI has been reported to be highly sensitive to changes in 
catecholamine neurotransmission (Braff et al., 2001; Zhang et al., 2000). Disorders associated 
with abnormalities in the CSPP circuitry that regulates PPI are accompanied by alterations in 
PPI. For example, deficient PPI has been reported in patients with Huntington’s disease 
(Swerdlow et al., 1995), Tourette’s syndrome (Castellanos et al., 1996), and schizophrenia 
(Braff et al., 1992); diseases which are presumably associated with dysregulated DA 
neurotransmission. Antipsychotic medication has been shown to normalize PPI deficits in 
schizophrenic patients (Csomor et al., 2009; Kumari et al., 2002; Leumann et al., 2002; 
Quednow et al., 2006). Especially alterations in the ventral part of the mesostriatal DA system 
(Braff et al., 2001; Zhang et al., 2000) and the thalamocortical and ventral forebrain NE 
networks are associated with changes in PPI (Alsene and Bakshi, 2011; Alsene et al., 2011; 
Oranje and Glenthoj, 2012; Oranje et al., 2004). Therefore, PPI classifies as an inexpensive and 
non-invasive measure (as compared to PET) to investigate neurochemical alterations in the 
CSPP circuit.  
In rats, acute cocaine administration has been shown to reduce PPI (Martinez et al., 1999), but 
lasting effects of repeated drug use are not well studied. CSPP circuits regulating PPI, and the 
reward system (shown to be altered in cocaine users) overlap in the ventral striatum. 
Therefore, PPI is supposed to be an appropriate measure to capture alterations of 
catecholamine functioning in cocaine users, which have been associated with craving, loss of 
control over drug intake, and relapse (Martinez et al., 2007; Volkow et al., 1997a; 1997b). 
Therefore, the study described in Chapter 3 aims to investigate 1) if dependent cocaine users 
show alterations in PPI that are known to be related to changes in neurotransmission 2) if 
already recreational drug use is associated with alterations in neurotransmission measured 
with PPI and 3) if ADHD symptoms which are highly comorbid with cocaine dependence and 
abuse and craving (Perez de Los Cobos et al., 2011), influence PPI.  




1.3.3 Social cognition 
The model of addiction proposed by Volkow et al. (2011a; 2003; 2011b) (see Chapter 1.1) 
implies that drug use should have consequences for social cognition, as sensitivity to social 
reinforcers might be reduced. Furthermore, dependent cocaine users show neurochemical and 
functional changes in brain areas related to social cognition (Hanlon and Canterberry, 2012; 
Volkow et al., 2011a). Moreover, social cognition is modulated by the DA system (Abu-Akel 
and Shamay-Tsoory, 2011), which is altered in cocaine users, as will be demonstrated in 
Chapter 3.  
Social cognition in drug users is particularly important, as social abilities and social support are 
critically involved in the onset of drug use (Ramirez et al., 2012; Shortt et al., 2007) and 
treatment success in addiction disorders (Homer et al., 2008; Volkow et al., 2011a). 
Pharmacological treatment approaches for cocaine addiction are currently lacking (O'Brien, 
2005) and treatment approaches such as cognitive behavioral therapy rely, at least partly, on 
the emotional responsiveness of the patients (Moos, 2007). Therefore, a characterization of 
social cognition deficits in cocaine users is important to improve the impact of treatment 
strategies for cocaine addiction. However, studies on social cognition in cocaine users have 
been lacking so far. Therefore, the study presented in Chapter 4 aims to investigate social 
cognition and real life social functioning in dependent and recreational cocaine users. 
As measures of social cognition, the Multifaceted Empathy Test (MET) (Dziobek et al., 2008), 
the Movie for the Assessment of Social Cognition (MASC) (Dziobek et al., 2006), and the 
Reading the Mind in the Eyes Test (RMET) (Baron-Cohen et al., 2001) were applied. The MET 
and MASC are recently developed tests, which rely on photo-realistic and video-based stimulus 
material and therefore offer more ecological validity than for example questionnaires or text-
based tests.  
The MASC is a naturalistic, video-based and PC-assisted test of mentalizing, which has been 
shown to be more sensitive than other mindreading tests (Dziobek et al., 2006), such as the 
strange stories task (Happe, 1994), RMET (Baron-Cohen et al., 2001), and basic emotion 
recognition (Ekman and Friesen, 1971). Participants are asked to watch a short movie about an 
everyday life situation (friends having dinner) and make inferences about the video characters’ 
mental states. This requires the understanding of different mental states such as emotions, 
thoughts, and intentions, and social cognition concepts, such as false belief, faux pas, 
metaphor, and sarcasm in an everyday life situation. Furthermore, valence, extent and quality 




of language, gestures, and facial expressions are varied. Therefore, the test covers a broad 
range of mental states that have to be inferred (Dziobek et al., 2006). The MASC has been 
reported to detect even subtle mindreading difficulties for example in healthy individuals of 
normal IQ (Hassenstab et al., 2007; Smeets et al., 2009), and patients with schizophrenia 
(Montag et al., 2011), borderline personality disorder (Preissler et al., 2010), and autism 
(Dziobek et al., 2006). The test has a good internal consistency with Cronbach’s α=0.84 and has 
been shown to be very stable over time with an interclass coefficient ICC = 0.97 over an 
average interval of 4.6 months. 
The MET requires participants to view photographs of people in emotionally charged situations 
and infer the mental state of the person in the photo, rate their empathic concern for the 
person, and judge their arousal while viewing the picture (Dziobek et al., 2008). The stimuli 
depict everyday life situations conveying information on emotional mental states via facial 
expression, body language, and context. The MET is based on the multidimensional model of 
empathy (Blair, 2005; Davis, 1983), and therefore is feasible to differentiate two facets of 
empathy: cognitive and emotional empathy. The cognitive aspect refers to the ability to 
understand another person’s mental state and emotion, without necessarily experiencing the 
same emotion or being in an emotional state (Baron-Cohen and Wheelwright, 2004; Walter, 
2012). Thus, the concept of cognitive empathy overlaps with affective Theory of Mind (ToM) 
(Walter, 2012) and mentalizing (Frith and Frith, 2003). Emotional empathy refers to the 
emotional response of a person to another person’s emotional state and therefore, the ability 
to feel what someone else feels (Mehrabian and Epstein, 1972). Thus, the MET is designed to 
create a more specific profile of empathic abilities than unidimensional tests and 
questionnaires of empathy used in previous studies (Baron-Cohen and Wheelwright, 2004; 
Blair, 1999). Moreover, through the use of photorealistic stimuli it aims to better capture 
empathic abilities than multidimensional empathy questionnaires (e.g., the Interpersonal 
Reactivity Index (Davis, 1980)) which hold lower ecological validity (Dziobek et al., 2008). The 
MET has been reported to detect deficits in cognitive empathy in patients with autism 
(Dziobek et al., 2008), and deficits in emotional empathy in patients with narcissistic 
personality disorder (Ritter et al., 2011). Internal consistency of the MET scales ranges from 
Cronbach’s α=0.71 to α=0.92 (Dziobek et al., 2008). 
When completing the RMET participants are asked to infer the mental state of a person from a 
photograph which depicts the eye region only (Baron-Cohen et al., 2001). The participants are 
supposed to choose one out of four mental state descriptors that describes the person’s 




feelings or thoughts best. Amongst others, autistic (Baron-Cohen et al., 2001) and 
schizophrenia patients (Kother et al., 2012) showed impaired abilities on mental state 
perception in the RMET. 
To assess real-life social functioning and behavior, the Social Network Questionnaire (SNQ) was 
conducted and the number and type of committed criminal offences was provided by the 
participants. The SNQ is a questionnaire designed to calculate the size of a persons’ social 
network. Furthermore, the experienced strain, and practical and social support by this network 
can be evaluated. It is based on the multidimensional social contact circle interview (Linden et 
al., 2007).  
Preliminary studies disclosed that dependent cocaine users might have difficulties in 
understanding, management, and regulation of emotions (Fox et al., 2007; Fox et al., 2011; 
Kemmis et al., 2007), and a 22-fold increased risk of antisocial personality disorder 
(Rounsaville, 2004). However, social cognitive abilities such as mentalizing and empathy have 
not been investigated in cocaine users so far. Therefore, the study presented in Chapter 4 
investigates these abilities using the MASC, MET, and RMET and relates the outcomes to real 
life social functioning and behavior measured with the SNQ and the reported criminal 
offences.  
  




1.4 Study samples 
 
1.4.1 Current and long-term abstinent heroin users 
Chapter 2 presents two studies on affective startle modulation in current and long-term 
abstinent heroin users. The fist study was carried out with 15 heroin-dependent subjects, who 
were enrolled in a residential detoxification program at the Department of Psychiatry of the 
University of Bonn, Germany. These participants underwent detoxification therapy with 
methadone, which was decreased within 8-12 days of inpatient treatment and had never 
received methadone maintenance prior to this therapy.  
The 15 long-term abstinent heroin users recruited for study II took part in a longitudinal-
investigation on the genetic influence on vulnerability to heroin dependence (Xu et al., 2004). 
Only heroin users who stated to be abstinent for at least one year were considered for this 
study. Abstinence was controlled by urine toxicology. None of these participants received 
methadone or heroin maintenance therapy. The control group was recruited from the general 
population. 
 
1.4.2 The Zurich Cocaine Cognition Study (ZuCo
2
St) 
The studies presented in Chapters 3 and 4 were part of a larger longitudinal investigation on 
the effects of cocaine use – the Zurich Cocaine Cognition Study (ZuCo2St). The study is 
designed to assess the impact of cocaine use on different measures of social and non-social 
cognition, impulsivity, and decision-making. Furthermore, the genetic basis of cocaine 
addiction, as well as glutamatergic changes measured with PET and structural and functional 
alteration measured with (functional) Magnetic Resonance Imaging (MRI) in cocaine users are 
investigated. Chapter 3 focuses on the early information processing and Chapter 4 on social 
cognition part of the ZuCo²St. Further data are discussed in different theses or are part of 
upcoming publications.  
One distinctive feature of the ZuCo2St is the inclusion of a non-addicted user group in addition 
to dependent users. Even though a substantial part of cocaine users use the drug in a 
recreational manner (EMCDDA, 2011), very little is known about this group, even though non-
addicted users offer the possibility to investigate factors that might influence the transition to 




dependence. Furthermore, this group holds the following advantages: They are 1) less 
burdened by psychiatric comorbidities (Smith et al., 2009), 2) less likely medicated with 
psychotropic drugs, and 3) display a reduced amount of polytoxic drug use.  
Another exclusive aspect is the application of comprehensive psychiatric diagnostics and hair-
toxicology offering the possibility to screen the drug use of up to six months before the testing. 
Out of 1063 requests via email or telephone 804 potential participants completed an initial 
telephone screening, whereof 240 fulfilled the inclusion criteria and participated in the study. 
Hair toxicology and urine samples were then applied to validate self-reports of drug use. Due 
to untruthful reports or the fulfilling of exclusion criteria, 46 participants had to be excluded, 
which resulted in a final sample of 108 cocaine users and 86 control subjects. Therefore, this 
sample is very well-described with little co-substance use and little psychiatric comorbidities, 
which is unique so far. Further details are presented in Chapters 3 and 4.  
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Models of addiction and addiction memory propose that drug-associated cues elicit incentive 
effects in drug users, which play an important role in maintenance of drug use and relapse. 
Incentive effects have been demonstrated for smoking and alcohol-related cues but evidence 
for heroin-related cues has been inconclusive. Furthermore, it is unknown whether appetitive 
effects of heroin-related cues persist after prolonged abstinence, although heroin addiction is 
known to have high relapse rates. Therefore, we investigated implicit and explicit valence of 
heroin-related cues in dependent users at different stages of abstinence using affective startle 
modulation. In Study I, 15 current heroin users were measured before and after detoxification. 
Correspondingly, 15 healthy control participants were tested twice at an interval of 14 days. In 
Study II, 14 long-term abstinent heroin users were additionally measured in a single session. 
Implicit processing of drug-related stimuli was assessed using affective startle modulation by 
pictures of heroin and smoking scenes. Explicit reactions were measured using ratings of 
valence and craving. In contrast to controls, heroin-dependent participants showed a clear 
reduction of startle response during heroin-related pictures (p<0.05). Detoxification did not 
significantly change their startle responses to heroin-cues. No difference between non-
detoxified current and long-term abstinent heroin users was found in implicit reactions to 
heroin-cues, whereas explicit measures differed between both groups (all p<0.05). After 
detoxification and even after prolonged abstinence, heroin cues still exert implicit appetitive 
effects in heroin users. This implies that drug-induced adaptations of reward circuits are long-
lasting, resulting in a highly stable addiction memory.  
 







Drug dependence, opiate dependence in particular, can be considered as a chronic relapsing 
disorder (Hser et al., 2001). Models of addiction propose that cue reactivity (i.e. elicitation of 
conditioned responses on psychological, physiological, and behavioral levels by drug-
associated stimuli) is of particular importance in the maintenance of drug use and relapse 
(Carter and Tiffany, 1999; Fatseas et al., 2011). Traditional theories of drug cues hold that 
drug-associated stimuli evoke conditioned reactions that trigger withdrawal-like and aversive 
responses (Koob et al., 1997; Wikler, 1973). More recently, there is evidence that drug-
associated cues may rather be processed as appetitive leading to the same behavioral and 
neurobiological responses like the drug itself (Dempsey et al., 2007; Geier et al., 2000; Mucha 
et al., 2000). Moreover, the incentive-sensitization theory proposes that drug consumption 
produces incremental neuroadaptations in the mesolimbic dopamine pathways, rendering 
them hypersensitive to drugs and drug-associated stimuli (Robinson and Berridge, 2000). This 
sensitization turns the act of drug taking and stimuli associated with it into powerful incentives 
that produce a strong feeling of “craving” for the preferred drug. Craving commonly refers to 
the subjective experience of wanting to use a drug (Tiffany and Wray, 2012) and the urge to re-
experience the effect of a psychoactive substance (UNDCP/WHO, 1992). 
This is in line with multiple theories of addiction memory, which propose shared mechanisms 
between memory, learning, and addiction (Berke and Hyman, 2000; Hyman and Malenka, 
2001; Hyman et al., 2006; Kelley, 2004; Robbins and Everitt, 2002; White, 1996). Repeated 
pairings of drugs and environment are supposed to produce long-term, maybe permanent, 
neuroadaptive effects in motivational networks that lead to the establishment of compulsive 
drug-seeking habits (Kelley, 2004; Robbins and Everitt, 2002). These associations and the 
craving elicited by drug-related stimuli might be in part unconscious (Tiffany, 1990). Drug 
memories are therefore supposed to be long-lasting and implicit. This assumption is consistent 
with high relapse rates among heroin users following treatment (O'Brien, 1997).  
A well-established non-subjective method to measure the implicit valence of drug-associated 
cues is the affective startle modulation (Geier et al., 2000; Rehme et al., 2009). The acoustic 
startle reflex (ASR) is a solid marker of emotional reactivity (Lang et al., 1990) and is elicited by 
unexpected, intense environmental stimuli such as a sudden, loud noise. The affect-modulated 





startle methodology has been repeatedly used in drug research by including photographs of 
drug paraphernalia or drug intake rituals and measuring the suppression of the startle 
response by drug-related scenes relative to neutral scenes (referred to as cue-related startle 
suppression, CSS). In general, these studies confirmed incentive theories because they 
consistently reported CSS in addicted users of alcohol or nicotine while viewing drug-related 
cues (Cinciripini et al., 2006; Dempsey et al., 2007; Geier et al., 2000; Mucha et al., 2000).  
Enhanced attentional processing of heroin cues and cue-induced reactivity have been 
demonstrated for heroin users with other methods, like Stroop tasks and electrodermal 
responses (Franken et al., 2000; Lubman et al., 2008), and some of these found that cue 
reactivity might be a predictor for future heroin use and relapse after treatment (Fatseas et al., 
2011; Lubman et al., 2009; Marissen et al., 2006). However, the implicit valence of heroin cues 
before and after detoxification and withdrawal therapy was not investigated so far. 
Furthermore, it is unknown whether heroin cues elicit appetitive effects in long-term heroin-
abstinent individuals. However, sustained appetitive value of drug-related cues might be a 
driving force underlying the high relapse rates in heroin addiction (Carter and Tiffany, 1999; 
Fatseas et al., 2011). 
Hence, we conducted two studies investigating the implicit valence of drug-related stimuli in 
different states of abstinence. In Study I, we analyzed the response to heroin-related cues in 
current heroin-dependent participants before and after a two week detoxification program, as 
well as in control participants tested within the same time interval. Smoking cues were used 
because of the common co-use of nicotine in heroin-dependent patients. For the same reason, 
for the control group only smokers were recruited. ASR was evoked during the presentation of 
positive, negative, and neutral pictures from the International Affective Picture System (IAPS) 
(Lang et al., 1997) and drug-related cues in order to assess the implicit valence of stimuli. The 
subjective evaluation of the stimuli was measured by ratings of valence and craving. According 
to sensitization and addiction memory theories, we hypothesized that heroin cues have 
appetitive effects in heroin-dependent participants before and after detoxification.  
The aim of Study II was to investigate the influence of successful long-term abstinence on 
affective processing of heroin-associated cues. Because of the significance of drug-related cues 
in relapse (Carter and Tiffany, 1999; Fatseas et al., 2011), it is important to investigate whether 
a history of opiate use is associated with persistent implicit memories and enhanced cue-
reactivity or if processing changes after successful abstinence. Therefore, a group of long-term 
abstinent heroin users was compared with current heroin users before detoxification and 





controls. Here, we expected long-term abstinent heroin-dependent participants to be more 
similar to current opiate users than to controls in their implicit reactivity towards heroin cues, 
as the incentive sensitization theory and addiction memory models posit memory traces to be 
persistent.  





2.3 Experimental procedures 
 
2.3.1 Participants  
Study I was carried out with two groups: 15 currently heroin-dependent participants and 15 
healthy participants with no history of opiate use (Table 1). Heroin-dependent participants 
were enrolled in a residential detoxification program at the Department of Psychiatry of the 
University of Bonn, Germany. Intravenous heroin dependence was diagnosed following the 
Diagnostic and Statistical Manual-IV (DSM-IV) criteria (American Psychiatric Association, 1994). 
Detoxification therapy was standardized by treatment with methadone (up to 20mg/day), 
which was decreased within 8-12 days of inpatient treatment. None of the patients in the 
detoxification program received methadone maintenance treatment prior to detoxification. 
The control group was recruited from the general population by advertisement.  
Study II compared a non-overlapping sample of 14 long-term abstinent heroin users (assessed 
once) with the 15 heroin-dependent participants (before detoxification) and 15 control 
participants (first measurement) from Study I. Long-term abstinent heroin users had to be 
diagnosed previously with intravenous heroin dependence according to DSM-IV criteria. They 
were recruited from a study on genetic influences on vulnerability to heroin dependence (Xu 
et al., 2004). In conjunction with a five-year follow up, only subjects who were abstinent for at 
least one year were considered for the present study (mean abstinence duration (SD)=18.93 
(±20.45) months). They did not receive methadone or heroin maintenance therapy. Abstinence 
was confirmed by urine toxicology.  
All participants were active smokers. Exclusion criteria comprised psychiatric or neurological 
disorders, and substance use disorders other than nicotine and opioid dependence for heroin 
users, use of psychotropic medication, and medical conditions concerning eyes, ears and 
equilibrium organs. 
The study was approved by the Ethics Committee of the Medical Faculty of the University of 
Bonn and was carried out in accordance with the declaration of Helsinki. After receiving a 
written and oral description of the aim of this study, all participants provided written 
informed-consent statements and received either 50€ (current heroin users and controls) or 
25€ (former heroin users) for their participation. 





2.3.2 Experimental procedures 
For Study I heroin-dependent participants were first tested when they started detoxification 
therapy (T1) and again when they finished therapy after 14 days of treatment (T2). 
Accordingly, control subjects were also tested on two experimental days with an interval of 14 
days. In Study II, long-term abstinent heroin users were tested once and compared to heroin-
dependent participants and controls at T1. Before the experiment, abstinent heroin users had 
to provide a urine sample to test for abstinence from opiates and other illegal drugs. 
All participants were asked for their drug history, daily cigarette consumption, momentary 
desire for heroin and momentary withdrawal symptoms by means of self-designed 
questionnaires. The questionnaire for withdrawal symptoms included 23 symptoms according 
to DSM-IV criteria. Their occurrence had to be rated on a 5-point scale. Further, the 
Mehrfachwahl-Wortschatz-Intelligenztest (MWT-A) (Lehrl, 1999), a standardized German 
vocabulary test, was carried out for the estimation of verbal intelligence quotient (IQ). The 
Hopkins Symptom Checklist (SCL-90-R) (Franke, 1995) was employed as a self-report 
psychological status symptom inventory. Before the startle procedure, all participants 
underwent a hearing screening to insure hearing within normal limits. Participants would have 
been excluded on the basis of hearing impairment at 40dB (1000Hz). Participants had to 
abstain from smoking for at least 60min prior to the study, as the acute effects of cigarette 
smoking have been shown to influence startle amplitudes (Kumari et al., 1996). The startle 
experiment was carried out in a calm and darkened room. Subjects were instructed to view the 
pictures and to ignore any noises from the headphones. After the startle procedure, all 
subjects viewed each picture individually and rated the perceived valence of the picture on 10-
point scales (i.e., “How do you perceive the present picture?”, 0=very unpleasant, 10=very 
pleasant), as well as their craving for nicotine and heroin (i.e., “How much desire to smoke/to 
take heroin does the present picture induce?”, 0=no desire, 10=strong desire). 
 
2.3.3 Stimulus material and presentation 
Stimulus material comprised 56 colored photographs, sixteen pictures showing the beginning 
and end of a heroin injection scene (Supplementary Figure S1), and 16 pictures showing the 
beginning and end of smoking a cigarette, which were taken from a previous study (Mucha et 
al., 1999, Experiment 2) (Supplementary Figure S2). Drug-associated stimuli depicted the 
beginning and end scenes of drug use because begin- and end-pictures of smoking and alcohol 





consumption scenes were shown to be processed differently (Mucha et al., 2008; Nees et al., 
2011; Stippekohl et al., 2010). Twenty-four control pictures comprised eight pleasant, neutral 
and negative scenes or objects, respectively. The task was presented using the Experimental 
Run Time System (ERTS) software (Berisoft Cooperation, Frankfurt, Germany). Details on the 
stimulus material are given in the Supplementary text. 
Pictures were arranged in two blocks of 28 photographs in a fixed-randomized and balanced 
order. Each block started with a 4-min habituation period of 70dB background white noise. The 
pictures were presented for 7 to 8s, followed by a black monitor lasting for 16.5 to 25.5s. 
During 6 out of 8 pictures (75%) of each category an acoustic startle response (ASR) was 
evoked, resulting in 40 ASR trials. The startle probe consisted of a burst of white noise with an 
intensity of 116dB (duration 40ms, instantaneous rise/fall time, bandwidth approximately 300 
Hz-18 kHz) presented binaurally using headphones (TDH-39-P; Maico). Startle probes were 
presented 2.5, 4.5, and 5.5s after picture onset.  
 
2.3.4 Data recording and reduction 
ASR was recorded and analyzed as described previously (Rehme et al., 2009). In brief, the eye-
blink component of the ASR was measured by an electromyographic (EMG) startle system 
(EMG-SR-Lab; San Diego Instruments, Inc., San Diego, CA). EMG activity was measured from 
the right orbicularis oculi muscle using two silver/silver chloride electrodes. A reference 
electrode was placed on the glabella. Detailed recording settings and data reduction 
procedures are given in the Supplementary material.  
 
2.3.5 Data analysis  
Demographic variables, smoking and heroin using behavior and craving measures were 
analyzed using analyses of variance (ANOVAs). Differences in sex distribution between groups 
were tested using χ²-tests.  
The individual startle amplitudes were standardized according to the individual mean and the 
standard deviation of the startle amplitudes of the control scenes. Standardization was 
appropriate as the raw startle magnitude showed strong variation across subjects (Patrick et 
al., 1993). Age was introduced as a covariate because it has been shown to influence affective 
startle modulation (Feng et al., 2011). Therefore, the standardized startle amplitudes were 
analyzed parametrically by mixed-design ANCOVAs controlling for age. The difference between 





the standardized amplitude during neutral scenes minus the standardized amplitude during 
drug-related scenes was used as an index for the CSS. Details on the data analyses are given in 
the Supplementary material. ANCOVAs were followed by Bonferroni-corrected pair-wise 
comparisons and simple main effects analyses. Statistical tests were considered significant at a 
level of p<0.05 (two-tailed). Analyses were performed using the PASW Statistics 18 for 
Windows.  







2.4.1 Study I: current heroin-dependent participants before and after detoxification therapy 
2.4.1.1 Demographic characteristics 
Healthy control subjects and heroin-dependent participants did not differ in verbal IQ, age, 
cigarettes smoked per day (CPD) or sex distribution. Heroin-dependent participants had less 
years of education (F(1,29)=8.56, p=0.007) and, as expected, scored higher on the SCL-90-R 
sum score (F(1,29)=9.23, p=0.005). Sociodemographic characteristics and drug use parameters 
are presented in Table 1 and 2. 
 
Table 1. Demographic characteristics (mean and standard deviation [SD]) of controls, current heroin users and 
former heroin users. Statistics were carried out for Study I (current heroin users vs. healthy controls) and Study II 













Current heroin dependent vs. 
healthy controls 
Study II 
Current heroin dependent vs. 
former heroin dependent vs. 
healthy controls  
Study I & II I & II II Value
a
 df/dferr p Value
a
 df/dferr p 
Male participants 12 14 9 χ2 = 1.154 1 0.283 χ2 = 3.758 2 0.153 
Age 29.53 (6.66) 30.93 (7.09) 35.57 (5.79) F = 0.311 1/29 0.582 F = 3.339 2/41 0.045* 
Years of education 10.87 (2.13) 9.20 (0.56) 10.36 (1.36) F = 8.562 1/29 0.007* F = 4.795 2/41 0.013* 
Verbal IQ 95.70 (10.97) 92.36 (7.08) 102.00 (5.97) F = 0.935 1/29 0.348 F = 4.800 2/41 0.014* 
SCL-90-R sum score 32.73 (26.11) 61.87 (26.41) 35.14 (26.33) F = 9.228 1/29 0.005* F = 5.628 2/41 0.007* 
Craving for heroin  
(0-80) 
- 31.07 (11.03) 24.78 (7.51) - - - F = 3.167 1/28 0.086 
Withdrawal 
symptoms (0-115) 
- 41.93 (12.81) 24.79 (7.51) - - - F = 8.133 1/28 0.008* 
a
ANOVA oder Chi²-test 
















Table 2. Duration and quantity of drug use of controls, current heroin users and former heroin users (mean and 
standard deviation [SD]). 
a
Days of use refers to the number of day on which the drug was used during the last 30 days. 
 
 
2.4.1.2 Startle modulation by negative, neutral and positive standardized stimuli
 
Raw startle magnitudes did not differ significantly between groups on first (T1) and second 
(T2) assessment (all p>0.250), although heroin users showed slightly decreased startle 
reactivity (Supplementary Material Figure S3). Negative, neutral and positive pictures from 
the IAPS induced a linear startle pattern (F(1,28)=19.83, p<0.001) in T1 and T2 (Figure 1A and 
B). The mixed-design ANCOVA yielded no group, time or picture category main effects (all 
p>0.220) and no significant interactions (all p>0.255). A priori predicted pair-wise comparisons 
revealed significant differences between negative and positive stimuli and positive and neutral 









Study I & II I & II II 
Heroin    
  Days of use
a
 - 28.00 (4.14) - 
  Years of use - 6.27 (3.77) 8.57 (7.35) 
Nicotine    
  Cigarettes per day (CPD) 19.60 (8.57) 20.17 (10.87) 16.62 (6.20) 
  Years of use 10.47 (5.37) 16.40 (3.05) 19.08 (5.68) 
Alcohol    
  Days of use
a
 6.40 (7.99) 6.80 (9.74) 3.50 (5.95) 
  Years of use 0.87 (2.64) 3.27 (3.73) 5.64 (6.92) 
Benzodiazepines    
  Days of use
a
 - 0.93 (1.94) - 
  Years of use - 1.00 (2.48) 0.30 (0.61) 
Cocaine    
  Days of use
a
 - 3.80 (8.18) - 
  Years of use - 0.67 (1.23) 4.54 (7.26) 
Amphetamines    
  Days of use
a
 - 0.4 (1.30) - 
  Years of use - 0.53 (1.30) 0.64 (1.34) 
Cannabis    
  Days of use
a
 2.73 (5.60) 3.13 (7.61) 2.43 (7.98) 






2.4.1.3 Drug cue effects  
A mixed-design ANCOVA revealed a significant time*category interaction (F(3,81)=3.17, 
p=0.030) and category*group interaction (F(3,81)=2.73, 
participants at T1 showed a significant CSS during heroin end (F(1,28)=5.78, 
smoking end pictures (F(1,28)=10.10, 
found during smoking end pictures (F(1,28)=12.07, 
T1 and T2 was found for smoking end pictures in heroin
p=0.004). In control participants, no significant differences were found between T1 and T2 (all 
p>0.268) (Figure 1C and D
Figure 1.  Mean standardized startle amplitudes during the presentation of control pictures on T1 (A) 
and T2 (B) and mean CSS during the presentation of drug
CSS was computed by subtracting the mean standardized startle amplitudes f
pictures from mean standardized startle amplitudes for neutral pictures. Means are adjusted 
for age. Error bars refer to SEM. *Indicates significant (p<0.05) differences between 
conditions (A and B) and significant (p<0.05) differences betw
amplitudes in neutral and drug






p=0.004). In control participants, a significant CSS was 
p=0.002). A significant difference between 
-dependent participants (F(1,28)=9.84, 
).  
-related cues on T1 (C) and T2 (D). 
een standardized startle 
-related scenes (C and D). 
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Indicates difference between 













2.4.1.4 Explicit picture rating (valence) 
A significant main effect for picture category on valence ratings was found for the control 
pictures (F(2,56)=120.94, p<0.001.) Both groups rated the IAPS pictures according to their 
assumed valence (all paired comparisons p<0.001) at T1 and T2 (data not shown).  
For drug-associated pictures, a significant main effect for category (F(3,81)=34.12, p<0.001) 
and significant interactions for category*group (F(3,81)=5.90, p=0.001) and time*group 
(F(3,81)=4.94, p=0.035) were found. At T1 and T2, heroin-dependent participants rated heroin 
begin and end cues significantly more positive than control participants (all p<0.010). No 
significant group difference was found for smoking pictures (all p>0.081).  
Furthermore, heroin-dependent participants rated heroin end pictures (F(1,28)=5.13, p=0.032) 
and smoking begin pictures (F(1,28)=11.68, p=0.002) significantly more pleasant after therapy 
than before, whereas control participants showed no change in their valence ratings between 
T1 and T2 (all p>0.468) (Figure 2A and B).  
 
Figure 2.  Mean valence ratings during drug-related pictures onT1 (A) and T2 (B) for controls (n=15) and 
current heroin users (n=15). Means are adjusted for age. Error bars refer to SEM. *Indicates 
significant (p<0.05) differences between groups.   
 
 
2.4.1.5 Explicit picture rating (craving) 
With regard to the ratings of craving for heroin, a significant main effect for group 
(F(1,25)=18.54, p<0.001) and category (F(3,75)=15.84, p<0.001) and a significant interaction for 
category*group (F(3,75)=15.91, p<0.001) were found. At T1, heroin-dependent participants 
reported more craving than controls for heroin begin (F(1,25)=11.410, p=0.002) and heroin 
end pictures (F(1,25)=13.53, p=0.001), while no significant difference was found for smoking 
cues. There was no significant difference in craving ratings between T1 and T2 (all p>0.093). At 
T2, heroin-dependent participants reported more craving for heroin than control subjects 





during all drug-related picture categories (heroin begin: F(1,25)=12.82, p=0.002; heroin end: 
F(1,25)=11.50, p=0.002; smoking begin: F(1,25)=4.23, p=0.050; smoking end: F(1,25)=4.91, 
p=0.036) (Figure 3A and B). Craving to smoke cigarettes differed neither between groups nor 
time points (Supplementary Material Figure S4A and S4B). 
 
Figure 3.  Mean craving for heroin-ratings during drug-related pictures on T1 (A) and T2 (B) for controls 
(n=15) and current heroin users (n=15). Means are adjusted for age. Error bars refer to SEM. 
*Indicates significant (p<0.05) differences between groups.   
 
 
2.4.2 Study II: Long-term abstinent heroin users 
2.4.2.1 Demographic characteristics 
Abstinent heroin users, heroin-dependent participants and control participants showed a 
comparable sex distribution (χ2(2)=3.75, p=0.153) and did not differ in CPD (F(2,42)=3.68, 
p=0.537). However, groups differed in age, years of education, IQ, and SCL-90-R sum score (all 
p<0.045). Abstinent heroin users and heroin-dependent participants differed in the heroin 
withdrawal score (F(1,28)=8.13, p=0.008) (Tables 1 and 2).  
 
2.4.2.2 Startle modulation 
For IAPS control pictures, the mixed-design ANCOVA yielded neither a significant main effect 
nor an interaction (all p>0.074). As a priori predicted, pair-wise comparisons revealed 
significant startle magnitude differences between negative and neutral stimuli (p<0.001) as 
well as between negative and positive pictures (p<0.001) (Figure 4A). 





Comparing startle magnitudes during drug-related cues between controls and abstinent heroin 
users, a 4*2 (category*group) mixed-design ANCOVA showed a significant main effect for 
group (F(1,26)=5.45, p=0.028). There was no significant difference between abstinent heroin 
users and current heroin-dependent participants (F(1,26)=0.68, p=0.419). Former heroin users 
showed a significant CSS for heroin begin and heroin end pictures (all p<0.050) (Figure 4B). 
Raw startle magnitude was slightly smaller in current heroin users, but did not differ 
significantly between groups (F(2,43)=1.12, p=0.335) (Supplementary Material Figure S5). 
 
Figure 4.  Mean standardized startle amplitudes during the presentation of control pictures (A) and 
mean CSS during the presentation of drug-related cues (B) for controls (n=15), current heroin 
users (n=15) and former heroin users (n=14). CSS was computed by subtracting the mean 
standardized startle amplitudes for drug-related pictures from mean standardized startle 
amplitudes for neutral pictures. Means are adjusted for age. Error bars refer to SEM. Controls 
and current heroin users in Study II are the same as in Study I. *Indicates significant (p<0.05) 
differences between conditions (A) and significant (p<0.05) differences between standardized 
startle amplitudes in neutral and drug-related scenes (B).  
 
 
2.4.2.3 Explicit picture rating (valence) 
For the IAPS pictures, there was a significant main effect of picture category (F(2,82)=66.13, 
p<0.001). The pictures were rated by all three groups according to their assumed valence (all 
paired comparisons p<0.001) (data not shown). 
For drug-associated pictures, there was a significant main effect for picture category 
(F(3,123)=43.50, p<0.001) and a significant interaction of category*group (F(6,123)=6.53, 
p<0.001). Abstinent heroin users rated heroin begin (p=0.022) and heroin end (p=0.028) 
significantly less pleasant than current heroin-dependent participants. No difference could be 





found between abstinent heroin users and controls in their valence rating of heroin-associated 
pictures (all p>0.427). Ratings for smoking pictures were not different between heroin-
dependent participants and abstinent heroin users (all p>0.705). Abstinent heroin users rated 
smoking begin cues (p=0.050) and smoking end pictures (p=0.033) significantly less pleasant 
than control participants (Figure 5A).  
 
2.4.2.4 Explicit picture rating (craving) 
The analysis of ratings of craving for heroin revealed a significant main effect for group 
(F(2,38)=10.21, p<0.001) and category (F(3,114)=12.38, p<0.001) and a significant interaction 
of category*group (F(6,114)=7.26, p<0.001). For heroin begin and end pictures, abstinent 
heroin users showed significantly less craving than current heroin-dependent participants 
(p=0.014, p=0.004). There was no difference in craving between controls and abstinent heroin 
users (all p>0.147). For smoking pictures, no group differences were found (all p>0.170) (Figure 
5B). Ratings of craving to smoke showed no significant group differences (Supplementary 
Material Figure S6).  
 
Figure 5.  Mean valence (A) and craving for heroin (B) ratings during drug-related pictures for controls 
(n=15), current heroin users (n=15), and former heroin users (n=14). Means are adjusted for 
age. Error bars refer to SEM. Controls and current heroin users in Study II are the same as in 
Study I. *Indicates significant (p<0.05) differences between groups. 







The present study assesses the implicit and explicit reactivity to heroin-related cues before and 
after detoxification therapy and after long-term heroin abstinence. Heroin-dependent patients 
show normally modulated affective reactivity to emotional control pictures suggesting that the 
overall emotional reactivity is not impaired, which is in line with Walter et al. (2011), who also 
failed to find differences in startle reactivity to emotional pictures. However, results are 
inconsistent with Lubman et al. (2008; 2009) reporting reduced responsiveness to natural 
reinforcers in heroin users previously. Heroin-dependent participants, in contrast to controls, 
show a significant reduction in startle response during stimuli depicting the end of a heroin 
injection scene compared to neutral stimuli. Valence ratings confirm that heroin users perceive 
heroin pictures as more pleasant than control participants, whereas both groups show no 
difference in valence ratings of smoking pictures. 
This is in line with incentive theories of addiction proposing that drug associated cues are 
processed as appetitive or motivational incentives (Robinson and Berridge, 2000; Stewart, 
1983; Wise, 1988). Incentive theories of drug addiction have been confirmed for other drugs, 
e.g., nicotine (Dempsey et al., 2007; Geier et al., 2000; Rehme et al., 2009) and alcohol 
(Grüsser et al., 2002; Heinz et al., 2003; Mucha et al., 2000), but results for heroin cues were 
undetermined so far. Walter et al. (2011) did not find a difference in startle response between 
neutral and drug-related stimuli, but opposed to our study, they used less specific and 
standardized drug pictures. Moreover, their patients were recruited from an opioid-
maintained treatment program and were treated with stable doses of methadone or heroin. 
Thus, opioid-maintanance might damp the emotional reactivity of heroin-dependent patients 
(Walter et al., 2011). Our finding that heroin-cues are not perceived as aversive but serve as 
emotional and maybe motivational incentives is also in line with recent findings suggesting 
enhanced activation of reward-related brain areas (e.g., the anterior cingulate cortex and basal 
ganglia) in response to heroin-related cues in heroin users (Wang et al., 2011).  
One novel finding is that the incentive value of heroin-related cues for heroin users persists 
after a 14-day detoxification therapy. Interestingly, explicit valence ratings imply that heroin 
end and smoking begin pictures are experienced as more pleasant after detoxification than 
before. These results are consistent with the finding that alcohol-related stimuli have 
appetitive qualities during alcohol detoxification and early abstinence (Grüsser et al., 2002). In 
addition, it has been shown that the reward system remains responsive to heroin-related cues 





in methadone maintenance patients with a history of heroin use (Langleben et al., 2008) and 
recent abstinence (Daglish et al., 2001). Nevertheless, craving in response to heroin-related 
cues did not change after detoxification therapy. This finding is in line with previous studies 
proposing a protracted abstinence syndrome even after longer drug free periods (Fatseas et 
al., 2011; Shi et al., 2007). Thus, strong appetitive effects of drug-related cues may support 
relapses after successful detoxification. 
Another novel finding of the present study is that implicit incentive effects can still be 
measured even after at least one year of abstinence. Former heroin users do not differ from 
current heroin users, both groups showing suppressed startle responses to heroin-related 
stimuli. Recently, Shi et al. (2008) found a persistent decrease in the brain dopamine 
transporter (DAT) in the striatum of prolonged abstinent heroin abusers. Together, these 
findings support theories of an addiction memory, possibly based on long-lasting, or even 
permanent alterations in the dopamine system, which increases the vulnerability to relapse 
even after long-term abstinence (Kalivas and Volkow, 2005; Kelley, 2004). In sum, these 
findings corroborate the close association between reward-related learning, memory, and 
addiction postulated by theories of addiction and addiction memory (Berke and Hyman, 2000; 
Hyman and Malenka, 2001; Hyman et al., 2006; Kelley, 2004; Robbins and Everitt, 2002; White, 
1996). 
Notably, the implicit appetitive reactions of former heroin users to heroin-related stimuli are in 
contrast with their explicit measures: Valence and craving ratings of heroin-related stimuli did 
not differ between former heroin users and controls. This finding supports the hypothesis that 
explicit and implicit processing of drug-related cues might be dissimilar (Grüsser et al., 2002; 
Tiffany, 1990). Even though sensitization of neural pathways seems to be persistent, former 
heroin users are obviously able to maintain abstinence. Top-down controlled processes might 
be supportive to inhibit drug-cue driven approach behaviors. Cognitive strategies of 
devaluating drug-related cues have been shown to enhance abstinence in smokers (Rose, 
2006). Recently, Min et al. (2011) reported higher abstinence rates when heroin users 
underwent a relapse prevention program after detoxification. The training of cognitive 
strategies to reduce the motivational impact of heroin-related cues should therefore be 
considered as a crucial part of relapse prevention programs. 
The present study has some limitations. First, the sample comprised mainly men, who differ 
from women in their subjective and physiological reactions to heroin-related cues as it has 
been previously shown (Yu et al., 2007). The results should therefore be replicated in women 
to be generalized. Second, even though urine toxicology confirmed current abstinence in 





former heroin users, abstinence duration measures rely on self-report and cannot be verified 
objectively, which is, however, an inevitable constraint. Third, in Study I, methadone treatment 
has been reduced two days before T2, which might have influenced emotional reactivity. 
However, Savvas et al. (2012), showed that effects of methadone on emotional processing 
were most prominent at peak plasma concentrations (around 3h post-dose) but 24h later no 
differences in emotional reactivity were found between controls and opioid-dependent 
subjects. Thus, we considered the residual influence of methadone on emotional reactivity to 
be very low at T2. Fourth, the sample size is moderate. However, this study (Study I) is the first 
longitudinal study employing an electrophysiological approach to measure the incentive value 
of drug-related cues. Moreover, it is also the first study comparing current and long-term 
abstinent heroin users with controls (Study II). Thus, despite of the moderate sample size this 
study provides unique insights regarding the stability of incentive values of heroin-related cues 
in heroin users. Finally, in Study I, it cannot be ruled out that test-retest effects influenced the 
results of the second assessment, although the startle reaction is involuntary and assessments 




Heroin-related cues showing the end of a heroin injection scene are appetitive in current 
heroin-dependent subjects, and these cues retain their appetitive valence even after a 
detoxification therapy of 14 days as well as after long-term abstinence for more than one year. 
These findings indicate that chronic heroin use leads to stable and long-lasting adaptations of 
neural pathways resulting in a high risk for relapse over a long time period. However, cognitive 
control processes seem to play a crucial role to maintain abstinence despite increased 
reactivity to heroin-related cues because explicit and implicit reactions are dissociated in long-
term abstinent heroin users. 
Further studies are needed to examine whether the implicit appetitive response to heroin-
related cues declines after prolonged abstinence for more than one year and whether this can 
be influenced by special treatment programs. Further, interventions which strengthen the 
devaluation of drug cues and apply stimulus control techniques should be part of relapse 
prevention programs.  
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2.11 Supplementary text 
 
Data recording and reduction 
The eye-blink component of the acoustic startle response was measured by an 
electromyographic (EMG) startle system (EMG-SR-Lab; San Diego Instruments, Inc., San Diego, 
CA). EMG activity was measured from the right orbicularis oculi muscle using two silver/silver 
chloride electrodes. A reference electrode was placed on the glabella. All electrode resistances 
were less than 10kΩ. EMG was recorded at a sampling rate of 1000Hz with a notch filter of 
50Hz and a band-pass filter between 1 and 1000Hz from the onset of the acoustic startle 
stimulus for 250 ms. 
Voluntary and spontaneous eye blinks were excluded from further analysis using the 
registration parameters described by Braff et al. (1992). The latency to startle response onset 
was defined by a shift of 2.28µV (six digital units) from the baseline value and occurring in a 
time window of 21–120ms after the acoustic startle stimulus. Response rejections were made 
both in case of onset-to-peak latencies >95ms and baseline shifts >34.2µV (>90 digital units). 
Additionally, startle responses were discarded if the amplitude was more than three standard 
deviations above the individual mean or if the amplitude was less than 25 digital units. The 
subject was taken out if there were less than two values per picture category after application 
of these criteria. Because the amplitude of the startle response underlies a habituation effect 
over trials (Bradley et al., 1993), we computed a regression analysis in order to correct our 
data against this effect. The decline of startle magnitude was best described by a logarithmic 
trend. Consequently, the raw data for every subject in the different trials were corrected for 
the logarithmic habituation trend. Finally, the available responses for the different picture 





























Figure S1. Heroin stimuli used in the affective startle paradigm. The sixteen self
injection scene. During the paradigm they were presented together with neutral, positive, negati
-taken pictures were produced as eight pairs showing the beginning and end of a heroin 

















Figure S2.  Smoking stimuli used in the affective startle paradigm. The sixteen self
scene. Pictures were taken from a previous study 
negative and heroin stimuli in a fixed randomized order.
-taken pictures were produced as eight pairs showing the beginning and end of a smoking 
(Mucha et al., 1999, Experiment 2). During the paradigm they were presented together with neutral, positive, 
 
 
















Figure S3. Mean raw startle magnitudes in μV in controls (n=15) and current heroin users (n=15) at T1 
and T2. Error bars refer to SEM. 
  





Figure S4. Mean craving for nicotine ratings during drug-related pictures on T1 (A) and T2 (B) for 
controls (n=15) and current heroin users (n=15). Means are adjusted for age. Error bars 
refer to SEM.  
 
  






Figure S5. Mean raw startle magnitudes in μV for controls (n=15), current heroin users (n=15) and 
former heroin users (n=14). Error bars refer to SEM. 
  





Figure S6.  Mean craving for nicotine ratings during drug-related pictures for controls (n=15), current 
heroin users (n=15), and former heroin users (n=14). Means are adjusted for age. Error bars 
refer to SEM. 
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Cocaine dependence has been associated with blunted dopamine and norepinephrine 
signaling, but it is unknown if recreational cocaine use is also associated with alterations of 
catecholamine systems. Prepulse inhibition (PPI) of the acoustic startle response (ASR) – a 
measure of sensorimotor gating – is highly sensitive for manipulations of the catecholamine 
system. Therefore, we investigated whether relatively pure recreational (RCU) and dependent 
cocaine users (DCU) display alterations of PPI, startle reactivity, and habituation. Moreover, 
the influences of methylenedioxy-methamphetamine and cannabis co-use, craving, and 




In 64 RCU, 29 DCU, and 66 stimulant-naïve control subjects, PPI of ASR, startle reactivity, 
habituation, ADHD symptoms, and cocaine craving were assessed. Drug use of all participants 
was controlled by hair and urine toxicologies. 
 
Results  
Both, RCU and DCU showed increased PPI in comparison with control participants (Cohen’s 
d=.38, d=.67, respectively), while RCU and DCU did not differ in PPI measures (d=.12). No 
significant group differences were found in startle reactivity or habituation measures. In 
cocaine users, PPI was positively correlated with cumulative cocaine dose used, craving for 
cocaine, and ADHD symptoms. Users with a diagnosis of ADHD and strong craving symptoms 
displayed the highest PPI levels compared with control subjects (d=.78). 
 
Conclusion 
The augmented PPI in RCU and DCU suggests that recreational use of cocaine is associated 
with altered catecholamine signaling, in particular if ADHD or craving symptoms are present. 
Finally, ADHD might be a critical risk factor for cocaine-induced changes of the catecholamine 
system. 
  




3.2 Introduction  
 
Cocaine is an illegal drug with a high tendency to induce dependence when chronically abused 
(1). Nevertheless, a substantial part of people use cocaine in a recreational and non-
dependent manner (2). The lifetime prevalence of cocaine use is estimated at 5.9% amongst 
15- to 34-year olds in Europe. It has been established as the most commonly stimulant drug 
used in Europe (2) and is the primary stimulant drug responsible for drug-dependence 
treatment in North and South America (3). 
Cocaine inhibits the reuptake of dopamine (DA), norepinephrine (NE), and serotonin (4). 
Marked structural and functional alterations in striatal and prefrontal regions have been 
reported in dependent cocaine users (DCU) (5-9). Furthermore, reduced striatal DA D2 
receptor availability and blunted striatal DA release have repeatedly been shown to be 
associated with chronic cocaine use in humans using positron emission tomography imaging 
(10-13). Striatal DA is a central mediator of reward, memory, and behavioral inhibition (14). 
Thus, dysregulated DA functioning in DCU has been associated with widespread consequences 
including craving, impulsive behavior, loss of control over drug intake, and relapse (12,13,15). 
Recently, upregulation of thalamic NE transporters also has been reported in DCU (16) and NE 
seems to play an important role in craving, withdrawal-related anxiety, and relapse in cocaine 
addiction (17,18). While most studies investigate dependent users, little is known about the 
effects of occasional and recreational cocaine use. However, a recent study showing blue-
yellow color vision deficits in recreational cocaine users (RCU) and DCU suggests that 
recreational cocaine use might lead to changes in DA function (19). 
 
Prepulse inhibition (PPI) of the acoustic startle response (ASR) refers to the attenuation of the 
reflexive startle reaction when the startling stimulus is preceded 30 milliseconds to 500 
milliseconds by a weak and non-startling stimulus (20). PPI is considered as a translational 
measure of sensorimotor gating, reflecting a universal preattentional filter function (21) that is 
regulated by a cortico-striato-pallido-pontine (CSPP) circuit involving the prefrontal cortex, the 
ventral striatum including nucleus accumbens, the ventral pallidum, and the pontine 
tegmentum (22). PPI has been shown to be highly sensitive to changes in catecholamine 
neurotransmission, especially in the ventral part of the mesostriatal DA system (23,24), and in 
thalamocortical and ventral forebrain NE networks (25-28). 




Acute administration of cocaine reduced PPI in rats (29), but lasting effects of repeated drug 
exposure are less well studied. In cocaine-withdrawn rats, no alterations in PPI were found 
(29,30). In humans, Efferen et al. (31) reported a trend towards increased PPI in a small sample 
of DCU (n=10 vs. n=9 control subjects). In this study, DCU displayed reduced startle reactivity 
(31), while a subsequent study revealed that decreased startle was only present in DCU with 
continued abstinence (>40 days) (32). With regard to startle reactivity, animal results are 
inconsistent. Adams et al. (30) showed reduced startle reactivity in cocaine-withdrawn rats, 
whereas Martinez et al. (29) found no significant differences in startle reactivity or habituation. 
However, PPI has not been studied in a sufficiently large sample of cocaine users so far. 
Moreover, the effects of recreational cocaine use on PPI and startle reactivity are unknown. 
The overlap of reward circuits shown to be altered in cocaine users (in particular the ventral 
striatum) and CSPP circuits regulating PPI suggests that PPI may be altered in cocaine addiction 
(9,10,22,23). 
 
Therefore, we aimed to investigate startle reactivity and PPI in large groups of RCU and DCU, 
and stimulant-naïve control subjects. Preliminary data from a previous study predict increased 
PPI levels and decreased ASR in DCU (31), while we expected to find a similar but less 
pronounced pattern already in RCU (19). Given that attention-deficit/hyperactivity disorder 
(ADHD) is highly comorbid with cocaine dependence and abuse (33) and it was shown that 
ADHD patients also display alterations in DA and NE signaling (34,35), we additionally assessed 
the severity of ADHD symptoms in our subjects. Moreover, we examined the severity of 
cocaine craving, as craving was associated with low striatal DA levels and NE alterations as well 
(12,36). Psychiatric comorbidities, such as ADHD, and polytoxic drug use have been shown to 
be confounded in studies especially with DCU (37,38). We aimed to overcome these previous 
limitations by I) the inclusion of a group of recreational and presumably less comorbid and 
polytoxic users, II) controlling ADHD symptoms, and III) the application of comprehensive 
psychiatric diagnostics and the examination of hair toxicologies, allowing the exclusion of 
subjects with psychiatric diseases (other than substance dependence or ADHD) and polytoxic 
drug use patterns. 







Twenty-nine DCU, 64 RCU, and 66 drug-naïve control participants took part in the study (for 
recruitment and selection details see Supplement 1). Cocaine dependence was diagnosed 
following the DSM-IV criteria (39), with DCU fulfilling these criteria and RCU not meeting 
dependency criteria. Further inclusion criteria for the two user groups were cocaine use of at 
least 1g per month, cocaine as primary used illegal drug, and a current abstinence duration <6 
months. Participants had to be aged between 18 and 60 years. Exclusion criteria for the user 
groups were use of opioids, a polytoxic drug use pattern, and an Axis-I DSM-IV adult 
psychiatric disorder with exception of cocaine and alcohol abuse/dependence, a history of a 
depression (acute major depression was excluded), and ADHD. Control subjects were excluded 
when they displayed any Axis-I DSM-IV psychiatric disorder, inclusive of ADHD, and any form of 
addiction or regular illegal drug use (lifetime use <15 occasions), with exception of cannabis. 
Exclusion criteria for all participants were a neurological disorder or head injury, clinically 
relevant medical diseases, family history of schizophrenia or bipolar disorder, or prescription 
drugs affecting the central nervous system, and medical conditions concerning eyes, ears, and 
equilibrium organs. All participants had to abstain from illegal substances for a minimum of 
three days and from alcohol for at least 24h. Self-reports were controlled by urine and 6-
month hair analysis (for details, see Supplement 1). 
The study was approved by the Cantonal Ethics Committee of Zurich. All participants provided 
written informed-consent and were compensated for their participation. 
 
3.3.2 Procedure 
The present data were collected as part of a larger longitudinal study on socio-cognitive 
consequences of cocaine use – the Zurich Cocaine Cognition Study (ZuCo2St). A Structured 
Clinical Interview for DSM-IV Axis I Disorders was carried out by a trained psychologist. Drug 
use was assessed by means of the Interview for Psychotropic Drug Consumption (40). The brief 
version of the Cocaine Craving Questionnaire (CCQ) (41) was applied to assess current cocaine 
craving. The Fagerström Test of Nicotine Dependence (FTND) (42) was used to assess the level 
of nicotine dependency. The Mehrfachwahl-Wortschatz-Intelligenztest (MWT-B) (43), a 




standardized German vocabulary test, was carried out for the estimation of premorbid verbal 
IQ. The Beck Depression Inventory (BDI) (44) measured the current severity of depressive 
symptoms, and the ADHD self-rating scale (ADHD-SR) (45) was applied to allow for the 
diagnosis of ADHD in adulthood according to DSM-IV criteria. A neuropsychological test 
battery was assessed (data will be published elsewhere) and subsequently the ASR 
measurement was conducted. Participants had to abstain from smoking for at least 60 minutes 
prior to startle testing.  
 
3.3.3 Startle response measurement 
For a detailed description of the paradigm, see Supplement 1. In brief, startle stimuli 
comprised of noise bursts at an 115dB sound pressure level with duration of 40 milliseconds, 
separated by variable inter-trial-intervals (range: 9-14 seconds, mean: 12 seconds). After an 
initial pulse-alone trial (PA) the session included a total of 64 trials (56 active and 8 no-
stimulation trials). Thirty-two pulse trials were preceded by a 20-msec prepulse with an 
intensity of 86dB and a stimulus onset asynchrony (SOA) of 30, 60, 120, and 240msec, resulting 
in four SOA conditions. The eye-blink component of the ASR was measured by an EMG startle 
system (EMG-SR-Lab; San Diego Instruments, San Diego, California) as described previously 
(21). Preprocessing of the recorded data was performed using Analyzer software (Brainvision; 
Brain Products GmbH, München, Germany) and emgBLINK version 1.2 (CST, Zurich, 
Switzerland) as described in detail previously (46).  
 
3.3.4 Statistical analysis 
Frequency data were analyzed by means of Pearson’s Chi-square test and quantitative data by 
analyses of variance (ANOVA) using PASW 18.0 (IBM, Chicago, Illinois). PPI and habituation 
data were normally distributed in each group (Kolmogorov- Smirnov test p>.05) and were 
therefore analyzed parametrically. The mean %PPI was calculated for each SOA as described 
previously (21,47). These data were analyzed using mixed-design analyses of covariance 
(ANCOVA) with Greenhouse-Geisser corrections, followed by Sidak-corrected pairwise 
comparisons and simple main effects analyses. SOA condition was introduced as within-
subjects factor and group as between-subjects factor. As smoking status, sex (3-fold: women 
differentiated by luteal vs. follicular phase of the menstrual cycle), and age were shown to 
influence startle parameters (48-52), these variables were introduced as covariates.  




Startle reactivity measures were analyzed likewise. To assess habituation, PA trials of block 1 
through 4 were analyzed conducting a mixed-design ANCOVA (53). Percent habituation was 
calculated as the reduction in startle magnitude between the second block and following 
blocks of PA trials [%Habituation=100*(block 2–block n)/block 2] to avoid sensitization effects 
(27). Furthermore, the linear gradient coefficient b was calculated across the four blocks of PA 
as described previously (47). %Habituation and b were analyzed by one-way ANCOVAs 
controlling for smoking status, sex, and age.  
Correlation analyses (Pearson’s product-moment) were conducted to relate drug use 
parameters to PPI measures. Cumulated cocaine lifetime use was natural logarithm-
transformed for statistical analyses because of the highly skewed distribution and the resulting 
deviation from the normal distribution (Shapiro-Wilk W<.001 for both user groups). For 
correlations between illegal drug use and PPI control subjects were excluded to prevent 
inflating existing correlations. The confirmatory statistical comparisons of all data were carried 
out on a significance level set at p<.05 (two-tailed).  






3.4.1 Demographic characteristics 
The groups did not differ with respect to IQ, sex distribution, and proportion of smokers and 
non-smokers (Table 1). DCU were older than controls and RCU (p<.05) and had fewer years of 
education than controls (p<.05). As expected, both user groups scored higher on the BDI and 
ADHD-SR sum scores compared with controls (all p<.01). FTND sum score differed between the 
smokers in each group (p<.05-.01). The hair samples revealed a clear dominance of cocaine 
compared with other illegal drugs as strived for by the inclusion criteria (Table 2). DCU showed 
a more than 7-fold higher concentration of cocaine and metabolites in the hair samples 
compared with RCU. However, RCU are regular users with a mean weekly consumption of 
about 1g cocaine but without fulfilling DSM-IV criteria for cocaine dependence. A considerable 
amount of participants tested positive in urine toxicologies for cocaine and cannabis and we 
decided not to exclude them but to investigate the acute and post-acute effects of the drugs. 
 
Table 1. Demographic Data (Means and Standard Deviation) 
 Control Group 
(n=66) 
Recreational cocaine users 
(RCU, n=64) 
Dependent cocaine users 
(DCU, n=29) 
Value df/dferr p 
       
Male/ female follicular/female luteal phase (n) 46/15/5 46/9/9 25/3/1 χ2 =5.94
a
 4 0.20 
Age (years) 31.11 (9.40) 28.11 (6.24) 36.28 (11.45)
b,c





Years of education  10.67 (1.87) 10.42 (1.91) 9.57 (1.24)
b





Verbal IQ 106.09 (11.20) 102.44 (9.00) 102.10 (10.97) F = 2.57
d
 2/156 0.08 
Smoker/Nonsmoker (n) 50/16 51/13 23/6 χ2 = 0.33
a
 2 0.85 
FTND sum score (0-10)
e









Craving for cocaine (0-70) - 18.92 (9.01) 18.97 (10.55) t = 0.02
g
 91 0.98 





















 6 0.43 
Sex, smoking,and haircolor in frequency data. 





 test (all groups) for frequency data. 
bIndicates significant post hoc test (Sidak) vs.control group: p<.05. 
cIndicates significant post hoc test (Sidak) vs. recreational cocaine user group: p<.05. 
dAnalysis of variance (all groups). 
eFTND measured in smokers only. 
fIndicates significant post hoc test (Sidak) vs.controlgroup: p<.01. 
gIndependent t test (cocaine users only). 














Recreational cocaine users 
(RCU, n=64) 




 df/dferr p 
Cocaine       
  times per week
b





 - 1.18 (1.46) 8.32 (16.15) F = 12.48 1/91 <0.001
h
 
  years of use - 6.08 (3.93) 10.35 (6.91) F = 14.30 1/91 <0.001
h
 
  maximum dose (24h) - 3.27 (2.37) 10.08 (8.49) F = 35.51 1/91 <0.001
h
 
  last consumption (days) - 24.70 (35.99) 28.39 (38.19) F = 0.19 1/91 0.66 
  cumulative dose (grams) - 500.61 (734.45) 7211.70 (10503.26) F = 26.19 1/91 <0.001
h
 
  urine toxicology (pos/neg) - 13/51 13/16 χ
2
 = 5.73 1 0.02
h
 
  hair sample (pg/mg)       
    cocaine - 2780.94 (4695.09) 19967.93 (33082.52) F = 16.75 1/91 <0.001
h
 
    benzoylecgonine - 565.51 (932.77) 4313.62 (7531.84) F = 15.53 1/91 <0.001
h
 
    ethylcocaine - 271.83 (312.28) 1879.31 (3721.96) F = 11.91 1/91 <0.001
h
 
    norcocaine - 63.45 (101.19) 501.64 (739.20) F = 21.87 1/91 <0.001
h
 
        
MDMA       
  tablets/week
b
 - 0.09 (0.27) 0.42 (1.86) F = 1.91 1/91 0.17 
  years of use 1.60 (11.31) 2.51 (3.81) 2.97 (5.35) F = 0.37 2/156 0.69 
  last consumption (days)
c
 - 66.33 (83.34) (n=20) 77.20 (45.91) (n=8) F = 0.12 1/26 0.73 
  cumulative dose (tablets) 0.61 (1.86) 37.70 (92.94) 139.10 (400.50)
d,e
 F = 6.00 2/156 <0.01
h
 
  hair sample (pg/mg) 2.74 (16.24) 627.24 (1660.04)
d
 240.86 (663.88) F = 5.15 2/153 <0.01
h
 
        
Cannabis       
  grams/week
b
 0.53 (1.47) 0.87 (2.01) 1.85 (4.84) F = 2.63 2/156 0.08 
  years of use 5.68 (7.32) 7.56 (5.65) 10.35 (10.66)
f
 F = 4.02 2/156 0.02
h
 
  last consumption (days)
c
 37.35 (52.23) (n=32) 20.67 (30.84) (n=43) 24.94 (30.72) (n=17) F = 1.66 2/89 0.20 
  cumulative dose (grams) 426.73 (903.46) 1082.74 (1780.72) 4491.36 (7478.60)
d,g
 F  = 14.84 2/156 <0.001
h
 
  urine toxicology (pos/neg) 12/54 23/40 11/18 χ
2
 = 6.58 2 0.04
h
 
       
Amphetamine       
  grams/week
b
 - 0.08 (0.21)
d
 0.01 (0.04) F = 2.58 1/92 0.11 




 F = 8.87 2/156 <0.001
h
 
  last consumption (days
)c
 - 63.10 (52.08) (n=24) 93.06 (74.12) (n=5) F = 1.19 1/27 0.29 
  cumulative dose (grams) 0.17 (1.44) 22.58 (59.01)
f
 16.70 (61.01) F = 4.10 2/156 0.02
h
 
  hair sample (pg/mg) 0.9 (7.56) 75.47 (259.52) 44.31 (158.97) F = 2.73 2/153 0.07 
        
GHB       
  cumulative dose (pipettes) - 1.79 (9.77) 1.14 (2.89) F = 0.12 1/91 0.73 
        
Hallucinogenes        
  cumulative dose (times) 1.80 (7.13) 6.78 (15.14) 8.07 (15.37) F = 3.69 2/156 0.03
h
 
        
Alcohol       
  grams/week
b
 118.83 (126.58) 174.96 (118.65) 196.09 (286.64) F = 2.97 2/156 0.05 
  years of use 13.83 (9.61) 10.84 (5.08) 14.73 (9.80) F = 3.22 2/156 0.04
h
 
        
Nicotine       
  cigarettes per day (CPD)
b
 9.03 (9.49) 11.96 (8.33) 15.60 (14.20)
f
 F = 4.43 2/156 0.01
h
 
  years of use 9.52 (9.68) 9.53 (6.34) 15.78 (11.33)
d,g
 F = 5.91 2/156 <0.01
h
 
Means and standard deviations in parentheses. Consumption per week, duration of use, and cumulative dose are averaged within the total group. 
GHB, gammahydroxybutyrate; MDMA, methylenedioxymethamphetamine. 
aAnalysis of variance or χ2 test for frequency data. 
bAverage use during the last 6 months. 
cLast consumption is averaged only for persons who used the drug in the last 6 months. In this case, sample size(n) is shown. 
dSignificant post hoc test (Sidak) vs.control group: p<.01. 
eSignificant post hoc test (Sidak) vs. recreational cocaine users group: p<.05. 
fSignificant post hoc test (Sidak) vs. control group: p<.05. 
gSignificant post hoc test (Sidak) vs.recreational cocaine users group: p<.01. 







A mixed-design ANCOVA (SOA*group) revealed a significant main effect for SOA 
(F(3,459)=9.50, p<.001) and a significant between subjects effect for group (F(2,153)=4.58, 
p<.01) (Figure 1). The main effect of SOA reflects the nature of PPI to increase with rising SOA 
(54). The interaction of SOA*group was not significant (F(6,459)=.97, 
pairwise comparisons showed a significantly increased mean %PPI for RCU (
DCU (p<.05, d=.67) compared with
other (p=.94, d=.12). A significant effect was found for the covariate sex (F(1,153)=4.95, 
(women in follicular phase and men>women in luteal phase), whereas the effects of age 
(F(1,153)=1.74, p=.19) and smoking status (F(1,153)=.64, 
Figure 1. Mean percent prepulse inhibition (PPI) in recreational (n=64) and dependent cocaine users 
(n=29) and healthy control participants (n=66). 
show significantly increased PPI. Error bars refer to SEM. *Significant difference between 
groups (p<0.05). SOA, stimulus onset asynchrony.
 
p=.44). Sidak
 controls, whereas RCU and DCU did not differ from each 
p=.43) did not reach significance. 














3.4.3 Startle reactivity and habituation 
Analyses of covariance performed for groups did not show significant differences in startle 
reactivity measures (all p>.42), although DCU showed slightly decreased startle reactivity 
compared with controls (d=.36, d=.43, respectively) (Table 3). Furthermore, no significant 
differences between groups were found for the mean of PPA trials and no-stimulation trials (all 
p>.53). Running the PPI analysis with and without covarying for PA first block yielded similar 
results. 
A mixed-design ANCOVA (PA trials block 1-4*group, smoking status, sex, age, and startle 
reactivity in block 1 as covariates) did not reveal a significant block*group interaction 
(F(6,411)=.40, p=.85), indicating that habituation did not differ between groups (Figure S1 in 
Supplement 1). Furthermore, %habituation did not differ between groups across blocks and 
neither did the linear gradient coefficient b (all p>.44) (Table 3). 
 
 
Table 3. Startle Reactivity, Mean %PPI, and Habituation 
  Control group 
(n=66) 
Recreational cocaine users 
(RCU, n=64) 




 df/dferr p 
PA first block (μV) 121.52 (103.54) 120.72 (68.46) 91.19 (61.15) F = 0.70 2/153 0.50 
PA mean across blocks (μV) 82.00 (61.23) 76.74 (51.13) 58.57 (45.29) F = 0.88 2/153 0.42 
PPA mean (μV) 6.60 (6.72) 6.40 (5.39) 5.28 (3.12) F = 0.31 2/153 0.74 
Baseline (μV) 3.07 (1.39) 2.96 (1.30) 3.04 (1.34) F = 0.63 2/153 0.53 




 F = 4.58 2/153 0.01
c
 
Habituation       
   %habituation block 2-3 20.05 (37.85) 23.17 (31.99) 12.23 (52.26) F = 0.83 2/153 0.44 
   %habituation block 2-4 25.68 (41.41) 26.91 (47.11) 32.10 (36.62) F = 0.32 2/153 0.72 
   coefficient b -21.68 (28.64) -21.34 (16.37) -19.06 (14.48) F = 0.12 2/153 0.89 
Means and standard deviations in parentheses 
PA, pulse alone trials; PPA, prepulse alone trials; PPI, prepulse inhibition. 
aAnalysis of covariance including all groups (sex, age, and smoking status as covariates). 
bIndicates significant post hoc test (Sidak) vs. control group: p<0.05. 
cSignificant p value.  
 
 
3.4.4 Correlations with cocaine use parameters 
In cocaine users, %PPI mean across SOA conditions was significantly correlated with cumulated 
cocaine use (ln-transformed) (r=.23, p<.03) and duration of cocaine use (r=.22, p<.03), 
indicating an increasing PPI with growing amount and time of use (Figure S2 in Supplement 1). 
The effects remained after adjusting for age. Correlations between %PPI mean across 
conditions and current cocaine use, as well as hair samples, did not reach significance (p>.28).  
 




3.4.5 Urine toxicology and drug use 
To test the influence of recent cocaine use, cocaine users were divided into users with positive 
(n=26, range: 268–43219ng/ml, mean: 5438ng/ml, SD: 10599ng/ml) and users with negative 
urine samples (n=67) and compared with control subjects (n=66). A mixed-design ANCOVA 
(SOA*group) revealed a significant between subjects effect for group (F(2,153)=4.83, p<.01). 
Sidak-corrected pairwise comparisons yielded a significantly increased mean %PPI in users with 
negative urine samples in comparison to controls (p<.01, d=.50). The SOA*group interaction 
did not reach significance (Figure S3 in Supplement 1). 
Analogously, the influence of recent cannabis use was investigated by dividing cocaine users 
into users with positive (n=34, range: 60–726ng/ml, mean: 120ng/ml, SD: 139ng/ml) and users 
with negative urine samples for cannabis (n=59). They were compared with controls with 
positive (n=12, range: 66–426ng/ml, mean: 163ng/ml, SD: 131ng/ml) and controls with 
negative urine samples (n=54). A mixed-design ANCOVA (SOA*group) revealed a significant 
between subjects effect for group (F(3,152)=3.33, p<.02). Sidak-corrected pairwise 
comparisons yielded still significant differences between users with negative urine samples 
and controls with negative urine samples (p<.01, d=.51) regarding mean %PPI (Figure 2). The 
interaction of SOA*group was not significant (F(9,453)=0.62, p>.78).  
An ANCOVA (with age and sex as covariates) of mean %PPI comparing controls and cocaine 
users stratified for smoking status revealed a significant group effect (F(3,153)=4.73, p<.01) 
(Figure 3). Non-smoking controls differed significantly from smoking cocaine users (p<.01, 
d=.90), while the difference to the non-smoking cocaine users was not significant (p<.30) 
despite the considerable effect size (d=.63) due to the small group sizes (n=16 vs. n=19). 





























Figure 2.   Mean %PPI in control participants with positive (n=12) and negative (n
cannabis and cocaine users with positive (n=34) and negative (n=59) urine samples for 
cannabis. Error bars refer to SEM. *S













Figure 3. Mean %PPI across SOA conditions in non
smoking control subjects
(n=19), and smoking cocaine users (cocaine users, s) (n=74). Error
*Significant difference between groups (Sidak 
nonsmoker. 
 
ignificant difference between groups (Sidak 
 
smoking control subjects 
 (controls, s) (n=50), nonsmoking cocaine users (cocaine users, ns) 
post hoc test: p<0.05).
 
 75 
=54) urine samples for 
post hoc 
(controls, ns) (n=16),   
 bars refer to SEM. 
 s, smoker; ns, 




3.4.6 Craving and ADHD 
In cocaine users, CCQ sum score correlated significantly with %PPI mean across conditions 
(r=.22, p<.03). Furthermore, when dividing users in a high and low craving group by median 
split and comparing them with control subjects (Figure S4 in Supplement 1), a mixed-design 
ANCOVA (SOA*group) revealed a significant main effect for group (F(2,153)=7.05, p<.001). 
Sidak-corrected pairwise comparisons revealed a significant difference between controls and 
cocaine users with high craving (p<.001, d=.69). Introducing cumulative cocaine use as a 
further covariate did not change the results. 
The ADHD-SR sum score was significantly correlated with mean %PPI across conditions in 
cocaine users as well (r=.25, p<.02). To test the influence of ADHD on PPI, cocaine users were 
divided into cocaine users with and without ADHD according to DSM-IV criteria and compared 
with controls (Figure S5 in Supplement 1). A mixed-design ANCOVA (SOA*group) revealed a 
significant main effect for group (F(2,153)=6.67, p<.002). Sidak-corrected pairwise comparisons 
revealed that cocaine users with ADHD showed a significantly increased PPI in comparison to 
controls (p<.001, d=.76). Interestingly, in cocaine users with ADHD PPI enhancement was most 
pronounced in the SOA 30 and 240 conditions. Cocaine use parameters did not differ between 
cocaine users with and without ADHD (all p>.47), and ADHD-SR sum score was not correlated 
with cocaine use parameters. Introducing cumulative cocaine use as a covariate in the mixed-
design ANCOVA (SOA*group) revealed similar results (group: F(2,152)=5.57, p<.005). 
When comparing cocaine users stratified for an ADHD diagnosis (yes/no) and craving 
(high/low) with controls (Figure 4), a mixed-design ANCOVA (SOA*group) revealed a significant 
main effect for group (F(4,151)=4.74, p=.001). Controls differed significantly from cocaine 
users with ADHD and high craving (p<.03, d=.78) and cocaine users without ADHD and high 
craving (p<.03, d=.66). Cocaine users without ADHD and low craving displayed normal PPI 
levels. Cocaine use parameters again did not differ between cocaine user groups. Introducing 






Figure 4.   Mean %PPI in cocaine users with ADHD and high craving (n=10), cocaine users with ADHD and 
low craving (n=12), cocaine users without ADHD and high craving (n=31), cocaine users with 
ADHD and low craving (n=40), and control subjects
and without ADHD show significantly augmented PPI, while cocaine users without craving and 
ADHD display widely normal PPI levels. Error
between groups (Sidak post hoc test: p<0.05).
 
 
 (n=66). High craving cocaine users
 bars refer to SEM. *Significant difference 












The present study demonstrates that both, RCU and DCU, showed clearly increased PPI levels 
compared with stimulant-naïve controls. Hair toxicologies and comprehensive psychiatric 
diagnostics allowed the analysis of a relatively pure and well-described group of cocaine users 
with little psychiatric comorbidities and without polytoxic drug use. Correlation analyses 
suggest a positive association between amount and duration of cocaine use and PPI. No 
significant differences between groups were found with regard to startle reactivity or 
habituation measures. Furthermore, PPI was significantly augmented in cocaine users with 
negative urine samples, while users who tested positive for cocaine displayed almost normal 
PPI levels at least in 60-msec and 240-msec SOA conditions. Finally, cocaine users with ADHD 
symptoms and high craving showed the strongest increase in PPI, while cocaine users without 
ADHD but high craving still showed significantly enhanced PPI. 
 
In the sole previous study, Efferen et al. (31) reported a statistical trend towards increased PPI 
in DCU, which was confirmed in the present investigation. Presumably because of the small 
sample size (10 cocaine users, 9 controls) and the analysis of only three out of six blocks of 
stimulus trials the effect did not reach significance before (31). In contrast to results obtained 
in short-term cocaine-withdrawn rats, showing no alterations in PPI (29,30), PPI seems to be 
sensitive to the lasting effects of cocaine use in humans and the species-specific results might 
be ascribed to differences in drug dose, route and duration of administration, abstinence 
period, and pharmacokinetics (55). 
The PPI increase most likely reflects alterations in catecholamine neurotransmission: 
1) As CSPP circuits regulating PPI and reward circuits, shown to be altered in cocaine users, 
overlap in the ventral striatum, changes of the striatal DA system are possible (10,11,22,23). 
This interpretation would be in line with previous studies reporting reduced striatal DA 
functioning in DCU by applying PET imaging (10-13). DA agonists decrease PPI in rodents 
(23,56) and humans (55,57). Furthermore, some DA-antagonistic antipsychotics increase PPI in 
rats (23,56,58,59) and humans (60,61), whereas others like haloperidol have been shown to 
have no effect or decrease PPI in humans (28,62,63). Thus, the role of striatal DA in the 
modulation the PPI might be more complex than a simple linear relationship between striatal 
DA concentration and PPI expression.  




2) An increase of thalamic NE transporter density has been reported in DCU (16) and growing 
evidence suggests an involvement thalamocortical and ventral forebrain NE transmission in 
the regulation of PPI (25-28,64). Therefore, also dysregulation of NE transmission in CDU as 
well as RCU might contribute to the current results (17). Changes of the NE system would also 
be in line with the present and previous findings of slightly reduced startle magnitudes in 
cocaine users, because pharmacological as well as developmental lesions of the NE system can 
cause reductions of startle reactivity (65-67).  
The finding that PPI was increased exclusively in cocaine users with negative urine samples 
further support the view that reduced catecholamine levels are responsible for this effect. 
Users with positive urine samples have used cocaine recently, which is supposed to enhance 
DA and NE levels and reduce PPI (29,57,68). Furthermore, increased PPI was significantly 
correlated with amount and duration of cocaine use, which suggests that the alterations in PPI 
might be substance-induced. PPI seems to be more sensitive to cumulative use compared with 
recent drug use patterns, as it did not correlate with weekly consumption or hair toxicologies, 
suggesting that rather long-term changes in catecholamine systems are associated with 
enhanced PPI. However, although correlations between PPI, cocaine use, and craving may 
indicate drug withdrawal-induced PPI augmentation, it cannot be ruled out that alterations in 
PPI and neurotransmitter signaling precede cocaine use and possibly represent a vulnerability 
to develop cocaine addiction.  
 
Replicating earlier studies, PPI was reduced in women in the luteal phase of the ovarian cycle 
(51,52). This was explained by an increase in estrogen during the luteal phase, which results in 
elevated striatal DA release (69). However, as the distribution of women in the luteal and 
follicular phase did not differ between groups and menstrual cycle combined with sex was 
included as a covariate, it is unlikely that PPI differences between cocaine users and controls 
can be attributed to sex or hormonal changes. 
 
In line with previous studies in humans (31) and rodents (30), startle reactivity and habituation 
were slightly reduced in DCU, but the differences did not reach significance. Though, previous 
results on startle reactivity have been somewhat inconsistent so far. Whereas Efferen et al. 
(31) reported decreased startle magnitudes in early abstinent cocaine users, Corcoran et al. 
(32) did not report significantly reduced startle reactivity until 40 days of abstinence. In our 
study, duration of self-reported cocaine abstinence was not correlated with startle reactivity 




(p=.80). Though, further studies are needed to disclose the influence of abstinence duration on 
startle reactivity and PPI in cocaine users. 
 
Additionally, we examined the influence of craving and ADHD on PPI, as craving has been 
associated with dysregulated striatal DA and NE levels (12,17,18,36). Furthermore, dysfunction 
of NE and DA neurotransmission have been proposed to underlie the pathophysiology in ADHD 
(34,35,70). ADHD symptomatology and craving both increased PPI in cocaine users compared 
with controls, even if amount and duration of cocaine use were controlled. Low craving scores 
were associated with widely normal PPI, independent of ADHD diagnosis. Previous studies 
reported no significant effect of ADHD on PPI in adults (71,72). However, two studies reported 
slight but non-significant increases of PPI in untreated (n=13) or treatment-withdrawn (n=22) 
adults with ADHD (72,73), while stimulant-treated ADHD patients (n=10) displayed somewhat 
lower PPI levels (72). Perhaps, these studies were underpowered and therefore did not reveal 
an increase of PPI, even though the study of Feifel et al. (71) did not find PPI differences 
between unmedicated adult ADHD patients (n=20) and controls (n=17). Maybe the PPI-
increasing influence of ADHD symptoms shown here only arises from an interaction of cocaine 
use and underlying ADHD pathophysiology. Taken together, our results might explain why 
ADHD patients seem to be more vulnerable for addiction than healthy subjects (74) because 
our results indicate that cocaine using ADHD individuals experience stronger craving symptoms 
(reflected by maximum PPI increase), possibly due to greater changes catecholamine systems. 
Additionally, given that we studied only unmedicated cocaine users, cocaine might also be 
utilized as a self-medication in our users showing ADHD symptoms (74). The need for self-
medication might reflect a dysfunctional catecholamine system, which in turn could be more 
vulnerable for neurochemical plasticity induced by cocaine. 
 
As cocaine users tested in this study showed minimal to moderate co-use of MDMA and 
cannabis, their influence on PPI was further analyzed. In previous studies, cannabis use did not 
show significant effects on PPI at least passive attention paradigms just as used here 
(40,75,76). However, controls with positive cannabis urine toxicology showed a slight even 
though non-significant increase of PPI, which is in line with several animal studies observing 
that acute administration of cannabinoid-1 receptor agonists increase PPI (77,78). However, 
controls and cocaine users with negative cannabis urine samples still significantly differed, 
indicating that our result cannot be explained by cannabis co-use (Figure 2). Moreover, we 
have previously shown that MDMA users also display elevated PPI levels (40) but here we did 




not find an additional increase of PPI in cocaine users with a limited co-use of MDMA. This 
difference may be explained by either a ceiling effect or by the exclusion of cocaine users with 
a regular or high use of MDMA in the present study. Given that also MDMA-naïve cocaine 
users displayed enhanced PPI levels (Figure S7 in Supplement 1) our results cannot be 
attributed to the MDMA co-use of some users. 
 
The study has some limitations: First, we have no objective measure of the duration of 
abstinence beyond urine toxicologies but have to rely on self-reports. Thus, we were unable to 
investigate the true effect of abstinence duration on startle parameters. However, it would 
have been nearly impossible to control for abstinence in our ambulant and voluntary study 
setting. Second, although this is one of the first investigations employing hair toxicologies in an 
electrophysiological study with cocaine users we can only rely on self-reports for illegal drug 
use prior to 3 to 6 months (depending on hair length), which is nevertheless an inevitable 
constraint in all studies with illegal drug users (79).  
 
In sum, RCU and DCU showed an increase of PPI that was correlated with duration and amount 
of cocaine use, as well as the strength of cocaine craving. These data suggest that already 
recreational use of cocaine is associated with altered catecholamine signaling, which is in line 
with our previous finding of altered blue-yellow color vision in RCU (19). Moreover, the 
elevation of PPI was most pronounced in subjects with clinically relevant ADHD symptoms and 
high craving. PPI might therefore provide a non-invasive, simple, and cheap measure to 
objectively capture acute stimulant craving symptoms. Finally, our data imply that ADHD might 
be a critical risk factor for cocaine-induced changes of catecholamine systems. 
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3.9 Supplemental information 
 
Supplemental Methods 
Recruitment and Selection Details 
Participants were recruited in the Zurich area by means of advertisements in local newspapers, 
drug prevention and treatment centers, psychiatric hospitals, and internet platforms. Eight-
hundred-four potential participants completed an initial telephone screening, whereof 240 
subjects participated in the study. Fourty-six participants had to be excluded afterwards 
because of hair analyses revealing illegal drug use not declared in the interviews (e.g., opioids, 
excessive MDMA use or polydrug use) or lack of cocaine use. Furthermore, the startle data of 
19 participants (11 controls, 8 cocaine users) could not be analyzed because of technical 
problems/equipment malfunction during the test session. Further 16 participants were 
excluded due to matching reasons (age, IQ, education, and smoking) between groups (9 
controls, 1 cocaine user), startle non-responding (2 controls), and hearing problems (4 cocaine 
users). Therefore, 159 datasets were included in the analysis. Hair samples were provided by 
156 subjects, as hair analysis was not possible by reason of an insufficient amount of hair for 
three control subjects. Women provided information on the days since their last menstruation. 
Women in the first 14 days of the cycle were considered in the follicular phase, in the last 14 
days in the luteal phase. 
 
Urine and Hair Toxicologies 
Urine toxicology analyses comprised the compounds/substances: tetrahydrocannabinol, 
cocaine, amphetamines, benzodiazepines, opioids, and methadone and were assessed by a 
semi-quantitative enzyme multiplied immunoassay method using a Dimension RXL Max 
(Siemens, Erlangen, Germany). 
To characterize drug use over the last six months objectively, hair samples were collected and 
analyzed with Liquid chromatography-tandem mass spectrometry (LC-MS/MS). If participants’ 
hair was long enough, one sample of six cm hair (from the scalp) was taken and subsequently 
divided into two subsamples of three cm length. The following compounds were assessed: 
cocaine, benzoylecgonine, ethylcocaine, norcocaine, amphetamine, methamphetamine, 




MDMA, MDEA, MDA, morphine, codeine, methadone EDDP (primary methadone metabolite), 
tramadol, and methylphenidate. 
For our routine protocol for drugs of abuse analysis a three step washing procedure with water 
(2 minutes shaking, 15ml), acetone (2min., 10ml) and finally hexane (2min., 10ml) of hair was 
performed. Then the hair samples were dried at ambient temperatures, cut into small snippets 
and extracted in two steps, first with methanol (5ml, 16hours, ultrasonication) and a second 
step with 3 ml MeOH acidified with 50 µL hydrochloric acid 33 % (3 hours, ultrasonication). The 
extracts were dried and the residue reconstituted with 50 µL MeOH and 500 µL 0.2 mM 
ammonium formate (analytical grade) in water. As internal standards deuterated standards of 
the following compounds were used, added as mixture of the following compounds: cocaine-
d3, benzoylecgonine-d3, ethylcocaine-d3, morphine-d3, MAM-d3, codeine-d3, 
dihydrocodeine-d3, amphetamine-d6, methamphetamine-d9, MDMA-d5. MDEA-d6, MDA-d5, 
methadone-d9, EDDP-d3, methylphenidate-d9, tramadol-d3, oxycodone-d3, and ephedrine-
d3. All deuterated standards were from ReseaChem (Burgdorf, Switzerland), the solvents for 
washing and extraction were of analysis grade and obtained from Merck (Darmstadt, 
Germany); LC-solvents were of HPLC grade and were obtained from Sigma Aldrich (Buchs, 
Switzerland). 
The LC-MS/MS apparatus was an ABSciex QTrap 3200 (Analyst software Version 1.5, Turbo V 
ion source operated in the ESI mode, gas 1, nitrogen (50 psi); gas 2, nitrogen (60 psi); ion spray 
voltage, 3500V; ion source temperature, 450°C; curtain gas, nitrogen (20 psi) collision gas, 
medium), with a Shimadzu Prominence LC-system (Shimadzu CBM 20 A controller, two 
Shimadzu LC 20 AD pumps including a degasser, a Shimadzu SIL 20 AC autosampler and a 
Shimadzu CTO 20 AC column oven, Shimadzu, Duisburg, Germany). Gradient elution was 
performed on a separation column (Synergi 4µ POLAR-RP 80A, 150x2.0 with a POLAR-RP 4x2.0 
Security Guard Cartridge, (Phenomenex, Aschaffenburg, Germany). The mobile phase 
consisted of 1mM ammonium formate buffer adjusted to pH 3,5 with formic acid (eluent A) 
and acetonitrile containing 1mM ammonium formate and 1 mM formic acid (eluent B). The 
Analysis was performed in MRM mode with two transitions per analyte and one transition for 
each deuterated internal standard, respectively. 
 
 




Startle Response Measurement 
Electromyographic (EMG) recording was performed in a sound-attenuated room. All 
participants underwent a short hearing test before the test session to ensure hearing within 
normal limits. Participants were informed that they would hear broadband noise and bursts 
over the headphones. They were asked to sit comfortably, stay awake, and keep their eyes 
open. The eye-blink component of the ASR was measured by an EMG startle system (EMG-SR-
Lab; San Diego Instruments, Inc., San Diego, CA). EMG activity was measured from the right 
orbicularis oculi muscle using two silver/silver chloride electrodes. A reference electrode was 
placed on the glabella. All electrode resistances were less than 10kΩ. The system recorded 
continuously over the whole session with a sampling rate of 4096Hz. Acoustic startle stimuli 
were presented binaurally using headphones (TDH-39-P; Maico). The test session started with 
a 2-min acclimation period of 70dB background broadband noise that was continued 
throughout the session. Startle stimuli comprised of noise bursts at an 115dB sound pressure 
level with duration of 40ms, separated by variable intertrial intervals (range: 9-14 seconds, 
mean: 12 seconds). After an initial pulse-alone trial (PA) the session included a total of 64 trials 
(56 active and 8 no-stimulation trials) and lasted 13 minutes. Thirty-two pulse trials were 
preceded by a 20ms prepulse with an intensity of 86dB and a stimulus onset asynchrony (SOA) 
of 30, 60, 120, and 240ms, resulting in four prepulse (PP) trial conditions. Rise and fall times of 
all stimuli were less than 1ms. Four startle stimuli were presented at the beginning (block 1) 
and four startle stimuli at the end (block 4) to assess habituation. Eight no-stimulation (NS) 
trials and eight prepulse-alone (PPA) trials were recorded to assess baseline EMG activity. PPA 
trials, NS trials and each of 4 prepulse trial conditions were presented in a pseudorandomized 
order in blocks 2 and 3. 
 






Cannabis and MDMA 
Groups of high and low cannabis and MDMA users were created by median split of cumulative 
use. Cannabis use (cumulative use, duration of use, grams per week) was not correlated with 
%PPI in the cocaine user group. An ANCOVA comparing the %PPI mean across conditions 
between cocaine users with no (n=9), low (n=41), and high (n=41) cannabis use did not reveal a 
significant difference (F (2,85)=.72, p=.49) (Figure S6). Introducing cumulative cannabis use as 
a covariate in the main PPI analysis did not alter the results.  
MDMA use measures (cumulative use, duration of use, tablets per week) were also not 
correlated with %PPI in the cocaine user group (all p>.31). The comparison of %PPI mean 
across conditions between cocaine users with no (n=26), low (n=37), and high (n=30) MDMA 
use did not reveal a significant difference (F (2,87)=.20, p=.82) (Figure S7). Moreover, 









Figure S1:  Habituation curve diagrammed as mean amplitude of PA trials in four blocks, corrected for 
startle reactivity in the first block (means ±SEM) for recreational (n=64) and dependent 
cocaine uses (n=29), and healthy control participants (n=66). Each block contains four 116-














Figure S2: Cumulative lifetime cocaine use in grams (ln
(A) and duration of cocaine use in years and mean 
reporting 30 years of cocaine use did not change the correlation between duration of cocaine use and %PPI (
 
-transformed) and mean % prepulse Inhibition (%PPI) across all conditions in cocaine users (











Figure S3: Mean %PPI in cocaine users with positive (n=26) and negative (n=67) urine samples for 
cocaine, and healthy control participants (n=66). Error bars refer to SEM. *indicates 














Figure S4: Mean %PPI in low (n=52) and high (n=41) craving cocaine users and controls (n=66). Cocaine 
users with high craving show increased PPI. Error bars refer to SEM. *indicates significant 














Figure S5: Mean %PPI in cocaine users with Attention
and without ADHD (n=72), and healthy control participants (n=66). Error bars refer to SEM. 




-Deficit/Hyperactivity Disorder (ADHD) (n=22) 












Figure S6: Mean %PPI across conditions in cocaine users with no (n=9), low (n=41) and high (n=41) 
cumulative cannabis use. The red line represents the PPI level of the controls without 
cannabis use for comparison. Error bars refer to SEM.  
 
  





Figure S7: Mean %PPI across conditions in cocaine users with no (n=26), low (n=37) and high (n=30) 
cumulative MDMA use. The red line represents the PPI level of the controls for comparison. 
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4.1 Abstract  
 
Chronic cocaine users consistently display neurochemical and functional alterations in brain 
areas involved in social cognition (e.g., medial and orbitofrontal cortex). Although social 
functioning plays a crucial role in the development and treatment of drug dependence, studies 
investigating social cognition in cocaine users are lacking. Therefore, we investigated mental 
perspective-taking (“Theory-of-Mind”) and emotional and cognitive empathy in recreational 
(RCU) and dependent (DCU) cocaine users. Furthermore, we related these measures to real-
life indicators of social functioning. One-hundred cocaine users (69 RCU, 31 DCU), and 68 
stimulant-naïve healthy controls were tested with the Multifaceted Empathy Test (MET), 
Movie for the Assessment of Social Cognition (MASC), and Reading the Mind in the Eyes Test 
(RMET). The Social Network Questionnaire (SNQ) was conducted to assess social network size. 
Furthermore, participants provided information on committed criminal offences. RCU and DCU 
showed less emotional empathy compared to controls (MET), whereas cognitive empathy was 
not impaired (MET, RMET). Additionally, DCU made more errors in mental perspective-taking 
(MASC). Notably, cocaine users displayed a smaller social network and committed more 
criminal offences, and both was linked to worse empathy. Moreover, higher cocaine use was 
correlated with less social contacts and diminished mental perspective-taking, while younger 
age-of-onset of cocaine use was associated with more pronounced empathy impairment. In 
conclusion, social cognition impairments in cocaine users were related to real-life social 
functioning and should therefore be considered in therapy and prevention strategies. 






Owing to the high addictive potential and the negative health consequences the use of cocaine 
is a major public health issue (Degenhardt and Hall, 2012; UNODC, 2011). Cocaine is the 
second most prevalent illegal drug after cannabis in the United States and Europe (EMCDDA, 
2012; HHS, 2011). The current lifetime prevalence for cocaine use in young adults is estimated 
at 6.3% in Europe (15-34 years) and 13.3% in the United States (18-25 years) (EMCDDA, 2012; 
SAMHSA, 2011). While most studies on the cognitive and behavioral consequences of cocaine 
use focus on dependent cocaine users (DCU), a substantial number of cocaine users show a 
recreational, non-dependent use pattern (EMCDDA, 2012). However, little is known about the 
neurobehavioral effects of recreational cocaine use, although recent studies suggest 
neurochemical alterations already in recreational cocaine users (RCU) (Hulka et al., 2012; 
Preller et al., in press). 
Social cognition is an important factor in the development, progress, and treatment of 
psychiatric disorders, as it was demonstrated for schizophrenia patients (Couture et al., 2006). 
Analogously, it was proposed that social cognition may play a crucial role in the origin and 
course of dependence as well as treatment success in stimulant abusers (Homer et al., 2008; 
Volkow et al., 2011). It has been suggested that addiction impacts brain circuits enabling social 
functioning by reducing the sensitivity to social reinforcers and enhancing the value of the 
drug of abuse. Additionally, impaired social cognition may contribute to the decay of social 
relationships in addicted patients (Volkow et al., 2011), which might have consequences for 
treatment success, as higher social support is associated with longer abstinence durations 
(Mutschler et al., 2012). 
Surprisingly, studies investigating social cognition in stimulant users are lacking, even though 
evidence accumulated that chronic cocaine users display neurochemical and functional 
alterations in brain areas critically involved in several facets of social cognition (Volkow et al., 
2011). In particular, marked structural and functional alterations have been reported in the 
medioprefrontal cortex (MPFC), orbitofrontal cortex (OFC), and anterior cingulate cortex 
(ACC), temporal cortices including insula, and striatal regions in DCU (Bolla et al., 2004; Ersche 
et al., 2011; Franklin et al., 2002; Kuhar and Pilotte, 1996; Makris et al., 2008; Volkow et al., 
1992). These areas have been associated with social reward (Krach et al., 2010), emotional 
empathy (Abu-Akel and Shamay-Tsoory, 2011; Fan et al., 2012), cognitive empathy, and 
theory-of-mind (ToM) (Blair, 2005; Fan et al., 2012; Gallagher and Frith, 2003; Vollm et al., 




2006). Difficulties in understanding, management, and regulation of emotions (Fox et al., 2007; 
2011; Kemmis et al., 2007) have indeed been reported in DCU, but social cognitive abilities 
such as ToM and empathy have not been investigated in cocaine users so far. As effective 
pharmacological treatments for cocaine addiction are missing (O'Brien, 2005), and social 
cognition and interaction might be relevant for treatment outcome in addiction, a 
characterization of social cognition abilities in cocaine users is crucial for the development of 
more effective prevention and psychotherapeutic treatment strategies. 
Therefore, the present study investigates empathy and mentalizing together with real-life 
social network characteristics in large groups of RCU and DCU, and stimulant-naïve control 
subjects. Participants completed three tasks to capture different facets of empathy and ToM: 
the Multifaceted Empathy Test (MET) (Dziobek et al., 2008), the Movie for the Assessment of 
Social Cognition (MASC) (Dziobek et al., 2006), and the Reading the Mind in the Eyes Test 
(RMET) (Baron-Cohen et al., 2001). These tasks rely on more ecologically valid stimuli 
compared to questionnaires or text-based material to meet the demands of everyday social 
life. The MET is based on the multidimensional model of empathy suggesting two facets of 
empathy: cognitive and emotional (Blair, 2005; Davis, 1983). The cognitive aspect relates to 
inferring emotions, the ability to take another persons’ perspective, and the understanding of 
another person’s mental state, without necessarily being in an affective state (Baron-Cohen 
and Wheelwright, 2004; Walter, 2012). Cognitive empathy therefore overlaps with the 
constructs affective ToM and mentalizing (Frith and Frith, 2003; Walter, 2012). The emotional 
aspect of empathy describes a person’s emotional response to another person’s emotional 
state, i.e., the ability to feel what another person feels (Mehrabian and Epstein, 1972). The 
MASC was developed as a video-based test of social cognition approximating everyday life 
demands to further differentiate aspects of cognitive empathy and mentalizing (Dziobek et al., 
2006). Finally, the RMET is an established test of attribution and decoding of mental states 
from the eye region of faces only (Baron-Cohen et al., 2001).  
As most previous studies regarding cognitive alterations focused on dependent cocaine use, 
little is known about the substantial number of cocaine users showing a recreational use 
pattern. Changes in attention, memory, color vision, and sensorimotor gating have been 
reported in RCU (Hulka et al., 2012; Preller et al., in press; Soar et al., 2012), but socio-
cognitive abilities have not been investigated yet. Notably, examining recreational users holds 
some further important advantages: RCU are i) not/not yet addicted, ii) less burdened by 
psychiatric comorbidities (Smith et al., 2009), iii) less likely medicated with psychotropic drugs, 
and iv) display a reduced amount of polytoxic drug use. This is essential given that polytoxic 




drug abuse and psychiatric comorbidities are major confounding factors in addiction research 
especially with DCU (Degenhardt and Hall, 2012; Prinzleve et al., 2004). Therefore, the 
application of comprehensive psychiatric diagnostics and the validation of self-reported drug 
use by hair toxicologies in the present study results in a well-described sample of cocaine users 
with relatively sparse co-substance use and little psychiatric comorbidities. Consequently, the 
present study investigates different facets of social cognition in relatively pure recreational 
and dependent cocaine users compared to an age-, sex-, and IQ-matched group of healthy and 
psychostimulant-naïve controls. Considering previous imaging findings of altered MPFC, ACC, 
and striatal function in cocaine users, we expect to find impairments in social cognition in 
cocaine users presumably linked to real-life social dysfunction such as a smaller social network.  




4.3 Methods and materials 
 
4.3.1 Participants 
Thirty-one DCU, 69 RCU, and 68 stimulant-naïve control participants were included in the 
study (for recruitment details see Supplementary Material Methods 1). Cocaine dependence 
was diagnosed following the Diagnostic and Statistical Manual-IV (DSM-IV) criteria (American 
Psychiatric Association, 1994), with only DCU fulfilling these criteria. Further inclusion criteria 
for the two user groups were cocaine use of at least 1g per month, cocaine as primary used 
illegal drug, and a current abstinence duration <6 months. Exclusion criteria for the user 
groups were use of opioids, polytoxic drug use, and an Axis-I DSM-IV adult psychiatric disorder 
with exception of cocaine, nicotine, and alcohol abuse/dependence, history of depression 
(acute major depression was excluded), and ADHD due to their high prevalence in cocaine 
users. Control subjects were excluded when they displayed any Axis-I DSM-IV psychiatric 
disorder including ADHD and any form of addiction (except nicotine), and regular illegal drug 
use (lifetime use <15 occasions) with exception of cannabis. Exclusion criteria for all 
participants were any neurological disorder or head injury, clinically significant medical 
diseases, family history of schizophrenia or bipolar disorder, or prescription of drugs affecting 
the CNS. All participants were asked to abstain from illegal substances for a minimum of three 
days and from alcohol for at least 24 hours. Self-reports were controlled by urine toxicology 
and 6-month hair analysis (for details see Supplementary Material Methods 1 and 2). The 
study was approved by the Cantonal Ethics Committee of Zurich (KEK). All participants 
provided written informed-consent in accordance with the declaration of Helsinki and were 
compensated for their participation. 
 
4.3.2 Procedure 
The present data were collected as part of a larger study on cognitive consequences of cocaine 
use – the Zurich Cocaine Cognition Study (ZuCo2St) (Preller et al., in press). A Structured 
Clinical Interview for Axis-I DSM-IV Disorders (SCID-I) was carried out by trained psychologists. 
Furthermore, participants completed the DSM-IV self-rating questionnaire for Axis-II 
personality disorders (SCID-II). Participants were asked about number and type of committed 
criminal offences. Drug use was assessed by means of the Interview for Psychotropic Drug 




Consumption (IPDC) (Quednow et al., 2004). The brief version of the Cocaine Craving 
Questionnaire (CCQ) (Tiffany et al., 1993) was applied to capture current cocaine craving. 
Smoking habits were assessed with the Fagerström Test of Nicotine Dependence (FTND) 
(Heatherton et al., 1991). The Mehrfachwahl-Wortschatz-Intelligenztest (MWT-B) (Lehrl, 
1999), a standardized German vocabulary test, was carried out for estimation of premorbid 
verbal IQ. The Beck Depression Inventory (BDI) (Beck et al., 1961) was used to assess current 
depression symptoms, and the ADHD self-rating scale (ADHD-SR) (Rosler et al., 2004) was 
applied to allow for the diagnosis of ADHD in adulthood according to DSM-IV criteria. Together 
with a classical neuropsychological test battery and a psychophysiological measurement (as 
published elsewhere) (Preller et al., in press) the participants completed the tasks described 
below. Further task details are described in the Supplementary Material Methods 3. 
 
4.3.3 Tests of social cognition 
MET: The MET is a reliable PC-assisted test comprising 40 photographs of people in 
emotionally charged situations (Dziobek et al., 2008). The stimuli depict everyday life 
situations conveying information on emotional mental states via facial expression, body 
language, and context. To measure cognitive empathy (CE) subjects are asked to infer the 
mental state of the person in the photograph and choose which of four words provided along 
with the picture describes best what the person in the picture is feeling. Explicit emotional 
empathy (EEE) is assessed by ratings of empathic concern (“How concerned are you for this 
person?”) on a visual-analogue scale within a range of 1-9 (1=not concerned to 9=very 
concerned) while viewing the photograph. Implicit emotional empathy (IEE) is measured 
analogously by arousal ratings (“How calm/aroused does this picture make you feel?”, 1=very 
calm to 9=very aroused). MET and MASC are implemented in Presentation (Version 14.1, 
Neurobehavioral Systems, Albany, CA).  
 
MASC: The MASC was developed as ecologically valid and video-based multimodal (visual and 
auditory input) test of social cognition (Dziobek et al., 2006). Participants are asked to watch a 
15-min movie and make inferences about the video characters’ mental states requiring the 
understanding of emotions, thoughts, and intentions, and concepts such as false belief, faux 
pas, metaphor, and sarcasm in an everyday-life situation (a dinner with friends). It is paused at 
45 times when questions about the actors’ feelings, thoughts, and intentions are asked (“How 




is Michael feeling?”). These questions are asked in a multiple-choice format with one correct 
answer and three distractors reflecting three different types of mistakes: i) insufficient mental 
state inferences (undermentalizing: reduced ToM), ii) excessive (overmentalizing), and iii) non-
mental state inferences (physical causation, no-ToM). Therefore, the MASC provides a sum 
score for the errors and three subscales for different error types. To control for non-social 
inference (e.g., about physical events), six control questions are asked during the test.  
 
RMET: The RMET involves inferring the mental state of a person from a photograph which 
depicts the eye region only (Baron-Cohen et al., 2001). The RMET comprises 36 photographs, 
for which the participants are asked to choose one out of four mental state descriptors (e.g., 
jealous, panicked) which describes the person’s feelings or thoughts best. The descriptors are 
varied for each item. A sum score is computed by adding up the number of correctly identified 
items.  
 
SNQ: The SNQ is based on the social contact circle interview and was designed to evaluate the 
size of an individual’s social network as well as the experienced emotional support and strain 
by this network (Linden et al., 2007). Participants are required to write down the names of 
personal contacts in the areas ’household’, ‘family’, ‘work or apprenticeship’, ‘friends’, 
‘neighbors’, and ‘others’. Only individuals with whom they were in direct contact (via personal 
encounters, phone calls, emails, or letters) during the previous four weeks should be included. 
Double entries of contacts are not allowed enabling the calculation of the total social network 
size. Furthermore, participants are requested to indicate how strongly they feel emotionally 
supported (e.g., solace and encouragement) by their social contacts on a 5-point scale (1=not 
at all; 5=very much). Analogously, they specify the emotional strain (e.g., feeling of being 
rejected) they experience by their social contacts. 
 




4.3.4 Statistical analysis 
Frequency data were analyzed by means of Pearson’s Chi-square test and quantitative data by 
analyses of covariance (ANCOVA) or multivariate analyses of covariance (MANCOVA) where 
appropriate using PASW 18.0 (IBM, Switzerland). In all (M)ANCOVAs, group was introduced as 
fixed factor. As groups differed in age and years of education (YoE), these variables were 
introduced as covariates in the analyses. Pearson’s product-moment correlations were 
calculated to relate drug use parameters to social cognition measures. Cumulated cocaine 
lifetime use was ln-transformed for statistical analyses because of the highly skewed 
distribution and the resulting deviation from the normal distribution (Shapiro-Wilk W<.001 for 
both user groups). For correlations between illegal drug use and social cognition measures 
control subjects were excluded to prevent inflating existing correlations. The confirmatory 
statistical comparisons of all data were carried out on a significance level set at p<.05 (two-
tailed). 






4.4.1 Demographic characteristics 
The groups did not differ with respect to IQ, sex distribution, and smoking status but DCU were 
older than controls and RCU (Table 1). DCU had fewer YoE than controls and RCU. As expected, 
both user groups scored higher than controls on the BDI and ADHD-SR sum scores as well as on 
the antisocial personality disorder (PD), and the narcissistic PD scale of the SCID II. Nicotine use 
(FTND sum score) was higher in DCU than in RCU and controls. Furthermore, RCU and DCU 
reported more criminal offences than controls. 
The hair samples revealed a clear domination of cocaine compared to other illegal drugs as 
strived for by the inclusion criteria (Table 2). DCU showed a more than 8-fold higher 
concentration of cocaine and metabolites in the hair samples compared to recreational users. 
A considerable amount of participants were tested positive in urine toxicologies. However, we 
decided not to exclude them but to investigate the acute and post-acute effects of the drugs. 
 
Table 1. Demographic data (means and standard deviation) 
 Control group 
(n=68) 
Recreational 
cocaine users (n=69) 
Dependet cocaine 
users (n=31) 
Value df/dferr p 
Male/female participants (n) 47/21 49/20 24/7 χ2 = 0.73
b
 2 0.70 
Age  29.81 (9.13) 28.09 (6.60) 34.81 (10.22)*°° F = 6.85
a
 2/165 <0.01 
Years of education  10.62 (1.67) 10.35 (1.91) 9.47 (1.18)**° F = 4.95
a
 2/165 <0.01 
Verbal IQ 104.87 (9.66) 103.17 (9.28) 101.81 (11.23) F = 1.15
a
 2/165 0.32 
Smoker/nonsmoker (n)  51/17 55/14 24/7 χ2 = 0.43
b
 2 0.81 
FTND sum score (0-10)
d
 2.45(2.26) 3.35 (2.22) 4.79 (2.52)**° F = 8.58
a
 2/127 <0.001 
Craving for cocaine (0-70) - 19.14 (8.64) 20.55 (11.65) T = 0.67
c
 98 0.50 
Antisocial PD (SCID II, 0-15)
e
 2.40 (2.12) 4.39 (3.23)** 4.39 (3.83)** F = 8.91
a
 2/159 <0.001 
Narcissistic PD (SCID II, 0-16)
e
 3.06 (2.48) 4.43 (2.56)* 5.11 (3.49)** F = 7.226
a
 2/159 <0.001 
ADHD-SR sum score (0-22) 7.56 (5.05) 13.43 (9.65)** 17.00 (8.51)** F = 17.93
a
 2/165 <0.001 
BDI sum score (0-63) 3.66 (3.45) 7.83 (6.58)** 11.35 (8.66)**° F = 19.08
a
 2/165 <0.001 
Criminal offences
f
        
   total 0.54 (0.98) 1.31 (2.07) 1.84 (2.12)** F = 6.23 2/140 <0.01 
   drug related 0.21 (0.45) 0.65 (1.07)* 1.40 (1.12)**°° F = 15.43 2/140 <0.001 
   non-drug related 0.33 (0.89) 0.66 (1.74) 0.44 (1.19) F = 0.68 2/140 0.51 
   cocaine related - 0.24 (0.62)* 0.80 (0.71)**°° F = 19.73 2/140 <0.001 
   non-cocaine related 0.54 (0.98) 1.05 (1.93) 1.04 (1.88) F = 1.86 2/140 0.16 
   forfeit 0.47 (0.89) 1.13 (1.98) 1.28 (1.54) F = 3.76 2/140 0.03 
   conviction 0.07 (0.26) 0.18 (0.61) 0.56 (1.23)**° F = 5.16 2/140 <0.01 
Significant p values are shown in bold. Means and standard deviation of means in parenthesis. 
FTND, Fagerstrom Test of Nicotine Dependence (in smokers only); PD, Personality Disorder; SCID, Structured Clinical Interview for 
DSM-IV Disorders; ADHD-SR, ADHD self rating scale; BDI, Beck Depression Inventory  
a
ANOVA (across all groups), 
b
χ2 test (across all groups) for frequency data or 
c
Independent T-Test (cocaine users only) 
 
d
FTND measured in smokers only, 
e
SCID-II available for 67 controls, 67 RCU, 28 DCU, 
f
Criminal offences data available for 57 
controls, 62 RCU, 25 DCU 
* indicates post-hoc (Sidak) vs control group  p<0.05 
** indicates post-hoc (Sidak) vs control group  p<0.01 
° indicates post-hoc (Sidak) vs recreational cocaine users group p<0.05 
°° indicates post-hoc (Sidak) vs recreational cocaine users group p<0.01 




Table 2. Pattern and amount of drug use: Results of the Psychotropic Drug Interview, urine toxicology, and hair 
samples 












Cocaine        
  times per week - 1.10 (1.08) 2.63 (2.46) T = 4.34
c
 98 <0.001 
  grams/week - 1.11 (1.43) 6.72 (14.72) T = 3.15
c
 98 <0.01 
  years of use - 6.32 (4.06) 9.66 (6.42) T = 3.16
c
 98 <0.01 
  maximum dose (24h) - 3.43 (2.45) 9.48 (8.57) T = 5.42
c
 98 <0.001 
  last consumption (days) - 27.45 (37.35) 21.62 (35.58) T = 0.73
c
 98 0.47 
  cumulative dose (grams) - 504.32 (751.12) 5325.44 (9505.37) T = 4.21
c
 98 <0.001 
  urine toxicology (pos/neg) - 10/58 14/17 χ2 = 10.75
b
 1 <0.01 
  hair sample (pg/mg)        
    COC - 2670.15 (4600.40) 22324.84 (32083.52) T= 4.97
c
 97 <0.001 
    BEC - 537.57 (913.16) 4710.65 (7284.00) T = 4.67
c
 97 <0.001 
    ECO - 258.71 (298.16) 1918.71 (3583.17) T = 3.82
c
 97 <0.001 
    NOC - 61.60 (99.77) 570.16 (733.30) T = 5.64
c
 97 <0.001 
         
MDMA        
  pills/week - 0.08 (0.26) 0.36 (1.79)  T = 1.26
c
 98 0.21 
  years of use 1.66 (11.15) 2.29 (3.62) 2.92 (5.19) F = 0.30
a
 2/165 0.74 
  last consumption (days) - 111.28 (110.63) (n=22) 81.00 (48.43) (n=8) T = 0.74
c
 28 0.46 
  cumulative dose (pills) 0.97 (2.96) 31.91 (86.66) 140.23 (387.41)**° F = 6.90
a
 2/165 <0.01 
  hair sample (pg/mg) 1.78 (14.46) 509.68 (1462.43)** 218.55 (633.69) F = 4.58
a
 2/162 0.01 
         
Cannabis        
  grams/week 0.56 (1.47) 0.95 (2.08) 1.20 (3.68) F = 1.00
a
 2/165 0.37 
  years of use 5.45 (6.82) 7.54 (5.91) 9.78 (10.06)* F = 4.08
a
 2/165 0.02 
  last consumption (days) 33.10 (46.98) (n=30) 19.81 (30.39) (n=45) 66.55 (218.64) (n=17) F = 1.38
a
 2/88 0.26 
  cumulative dose (grams) 821.85 (3433.07) 1001.10 (1742.07) 3259.86 (5957.33)**° F  = 5.62
a
 2/165 <0.01 
  urine toxicology (pos/neg) 10/58 15/53 10/21 χ2 = 4.04
b
 2 0.13 
       
Amphetamine        
  grams/week - 0.06 (0.11) 0.04 (0.18) T = 0.60c 98 0.56 
  years of use 0.01 (0.06) 1.53 (2.97)** 1.49 (3.12)* F = 8.85a 2/165 <0.001 
  last consumption (days) - 61.25 (51.84) (n=25) 78.38 (75.42) (n=6) T = 0.67c 29 0.51 
  cumulative dose (grams) 0.19 (1.42) 17.02 (44.38)* 21.49 (61.88)* F = 4.59a 2/165 0.01 
  hair sample (pg/mg) 0.9 (7.39) 84.85 (257.79)* 57.74 (166.85) F = 3.69a 2/162 0.03 
         
GHB        
  cumulative dose (pipettes) - 1.64 (9.39) 1.24 (2.85) T = 0.23c 98 0.82 
         
Halluzinogenes         
  cumulative dose (times) 1.46 (6.88) 6.45 (14.73)* 6.57 (11.70) F = 3.83a 2/165 0.02 
         
Alcohol        
  grams/week 119.11 (126.73) 176.53 (115.95) 192.32 (256.31) F = 3.38a 2/165 0.04 
  years of use 13.23 (9.39) 10.98 (5.22) 13.92 (9.31) F = 2.01a 2/165 0.14 
         
Nicotine        
  cigarettes per day (CPD) 9.18 (9.92) 12.43 (9.00) 15.70 (13.98)* F = 4.43a 2/165 0.01 
  years of use 9.05 (9.75) 9.39 (6.38) 13.98 (9.24)*° F = 4.07a 2/165 0.02 
Significant p values are shown in bold. Means and standard deviation of means in parenthesis. 
Consumption per week, duration of use, and cumulative dose are averaged within the total group. Last consumption is averaged 
only for persons who used the drug in the last 6 months.  
In this case, sample size (n) is shown.  
Pg/mg = picogram/milligram. The hair analysis was performed on two hair samples (each 3 cm in length) per participant capturing 
drug use over the last six months. Concentrations were averaged over the two samples. If the hair sample was not long enough, 
only one sample was analyzed (3 cm, 3 months). MDMA = 3,4-methylenedioxy-N-methylamphetamine; methylenedioxy-
amphetamine, Cut-off value for cocaine = 500 pg/mg, for amphetamines and MDMA = 200 pg/mg 
a
ANOVA (across all groups), 
b
χ2 test (across all groups) for frequency data or 
c
Independent T-Test (cocaine users only) 
* indicates post-hoc (Sidak) vs control group  p<0.05 
** indicates post-hoc (Sidak) vs control group  p<0.01 
° indicates post-hoc (Sidak) vs recreational cocaine users group  p<0.05 






4.4.2 Multifaceted Empathy Test (MET)
A MANCOVA (with age and YoE as covariates) performed for the dependent variables CE, EEE, 
and IEE revealed a significant main effect for group (F(6,324)=2.63, p<0.02). Groups differed on 
the EEE (F(2,163)=7.94, p<0.01) and IEE scales (F(2,163)=5.40, p<0.01)
difference was found for CE (F(2,163)=0.98, p=0.38)
comparisons revealed a significant difference between controls and RCU (p<
between controls and DCU (p<0.05, d=0.49) in EEE. Similarly, in IEE a significant difference was 
found between controls and DCU (p<0.01, d=0.64), and controls and RCU (p<0.05, d=0.39).
As expected, the scores on the antisocial and narcissistic PD scales were significantly 
correlated with EEE and IEE 
covariate did not change the main results. Craving did not influence the resul
users with high craving, low craving, and controls did not reveal a significant main effect for 
group (Supplementary Material Figure 1)
both, cocaine users with and without ADHD (p<0.04, d=0.40
Figure 2), and cocaine users with high and low BDI scores (p<0.05, d=0.39
(Supplementary Material Figure 3)
with low ADHD and depression symptoms display defic
Figure 1.  Mean explicit (EEE) and implicit emotional empathy ratings (A) and mean of correct answers 
on the cognitive empathy (CE) scale (B) of the multifaceted empathy test (MET) for 
recreational (n=69) and dependent cocaine users (n=31), and healthy control participant
(n=68). Recreational and dependent cocaine users show less IEE and EEE than controls. No 





 (Figure 1B). Sidak
(Table 3), but introducing antisocial or narcissistic PD as a 
. Furthermore, controls showed more empathy than 
-0.68) (Supplementary Material 
 on the EEE and IEE scale, indicating that even cocaine users 

















Table 3. Correlations between test outcomes, real-life measures of social functioning, and clinical measures in 100 
cocaine users, 68 controls and (total n=168). 
    MET 
CE 












PD (SCID II) 
Narcissistic 
PD (SCID II) 
MET EEE 
controls           
cocaine user           
total           
MET IEE 
controls  0.91         
cocaine user  0.85         
total  0.89         
MASC total 
errors 
controls -0.29          
cocaine user -0.35          
total -0.32          
RMET Sum 
score 
controls 0.24   -0.40       
cocaine user 0.36   -0.35       




controls           
cocaine user           
total  0.18  -0.16 0.16      
BDI sum 
score 
controls           
cocaine user    0.23       
total   -0.16 0.21  -0.20     
ADHD-SR 
sum score 
controls     0.24  0.51    
cocaine user    0.28   0.53    
total  -0.20 -0.15 0.18  -0.17 0.60    
Antisocial 
PD (SCID II) 
controls   -0.32        
cocaine user  -0.22   -0.24   0.21   
total  -0.28 -0.29  -0.21   0.30   
Narcissistic 
PD (SCID II) 
controls  -0.31 -0.28    0.26 0.44   
cocaine user        0.38 0.40  




controls           
cocaine user         0.43  
total   -0.17     0.21 0.44  
Correlations with p<0.01 are shown in bold, correlations with p>0.05 are not shown 
ADHD-SR, ADHD Self-Rating scale; BDI, Beck Depression Inventory; PD, Personality Disorder; SCID, Structured Clinical Interview for 
DSM-IV Disorders; SNQ, Social Network Questionnaire, MET, Multifaceted Empathy Test; CE, Cognitive Empathy; EEE, Explicit 
Emotional Empathy; IEE, Implicit Emotional Empathy; MASC, Movie for the Assessment of Social Cognition; RMET, Reading the 
Mind in the Eyes Test; CCQ, Cocaine Craving Questionnaire. 
 
 
The impact of the age of cocaine use onset (AoO) was investigated by a MANCOVA 
(additionally corrected for cumulated cocaine use), with cocaine users split according to their 
AoO (AoO≤18: n=27, AoO>18, n=73) compared to controls (n=68). This revealed a main effect 
for group (F(6,322)=3.18, p<0.01) with groups differing in EEE (F(2,162)=10.41, p<0.01) and IEE 
(F(2,162)=15.53, p<0.001). Controls differed from cocaine users with early AoO on the EEE and 
IEE scale (all p<0.01, d=0.90). On the IEE scale, cocaine users with early AoO differed from 
cocaine users with AoO≤18 (p<0.01, d=0.63), whereas cocaine users with AoO>18 did not 
differ from controls on both scales (all p>0.21) (Figure 2). No group differences were found for 
CE (F(2,162)=0.36, p>0.70). Moreover, cocaine users with positive urine samples did not differ 





Figure 2.  Mean explicit and implicit emotional empathy ratings of the multifaceted empathy test (MET) 
in cocaine users with an age of onset (AoO) of cocaine use 
controls (n=68). Cocaine users 
empathy than controls and less implicit empathy than cocaine user with an AoO >18. Error 
bars refer to SEM. *indicates significant difference between groups (p<.05)
 
 
4.4.3 Reading the Mind in the 
An ANCOVA (with age and YoE as covariates) did not reveal any significant differences 
between groups regarding the RMET sum score (F(2,163)=0.55, p>0.58; mean [SD] for controls: 
25.47 [3.82]; RCU: 25.09 [3.43], DCU: 24.16 [3.85]). 
 
4.4.4 Movie for the Assessment of Social Cognition (MASC)
An ANCOVA (corrected for age and YoE) of the MASC total errors yielded a main effect for
group (F(2,164)=3.41, p<0.05). Sidak
difference between DCU a
(p=0.17, d=0.46) and controls (p=0.97, d=0.09)
of error as dependent variable revealed a significant main effect for group (F(6,324)=2.41, 
 
≤18 (n=27) and >18 (n=73), and 
with an AoO≤18 showed less explicit and implicit emotional 
Eyes Test (RMET) 
 
 
-corrected pairwise comparisons revealed a significant 
nd controls (p<0.05, d=0.55), while RCU did not differ from DCU 










p<0.03), with groups differing on the excessive ToM scale (F(2,163)=4.62, p<0.01). Sidak
corrected pairwise comparisons showed that DCU made more errors with regard to excessive 
ToM than RCU (p<0.02, d=0.61) and controls (p<0.02, d=0.58). RCU did not differ from c
(p=0.99, d=0.03) (Figure. 3B).
items (F(2,163)=1.85, p=0.16) and introducing control items as a covariate in the analysis did 
not reveal different results. Introducing narcissistic and
change group differences for MASC total errors. 
ANCOVAs testing the influence of recent cocaine use, craving, depressive symptoms, and AoO 
did not reveal significant group differences (all p>0.09), suggesting that the
critically influence the results. However, cocaine users with ADHD performed significantly 
worse than controls (p<0.01, d=0.72) and cocaine users without ADHD (p<0.02, d=0.63). 
Cocaine users without ADHD did not differ from controls (p
Material Figure 4). Nevertheless, introducing ADHD
did not change the main group effect.
 
Figure 3.  Mean total errors (A) and mean of error types (B) for the assessment of social cognition 
(MASC) for recreational (n=69) and dependent cocaine users (n=31), and healthy control 
participants (n=68). Dependent cocaine users made more errors in total than cont
more errors regarding overmentalizing (excessive theory






 Groups did not differ with regard to performance in the control 
 antisocial PD as a covariate did not 
 
>0.92, d=0.09)
-SR sum score as an additional covariate 
 
-of-mind [ToM]) than controls and 














4.4.5 Social Network Questionnaire (SNQ)
Social network data were available for 65 controls, 62 RCU and 27 DCU. Differences between 
groups for the social network size were analyzed with an ANCOVA (corrected for age and YoE), 
resulting in a significant main effect for group (F(2,149)=6.34, p<0.01). Bo
d=0.52) and DCU (p<0.01, d=0.70) reported a smaller social network than controls 
A MANCOVA with group and scale (emotional support/strain) as fixed factors revealed a 
significant main effect for scale (F(1,139)=9.48, p<0.01) a
interaction (F(2,139)=4.04, p<0.02)
less emotional support and more emotional strain than controls. 
An ANCOVA (additionally corrected for cumulated cocaine use) with coca
according to their AoO compared to controls (n=65) revealed a significant main effect for 
group (F(2,149)=5.39, p<0.01): controls differed significantly from cocaine users with AoO





















Figure 4.  Mean of total contacts (A) and mean of emotional support and strain ratings (B) assessed 
with the social network questionnaire (SNQ) for recreational (n=62) and dependent 
cocaine users (n=27) and 
contacts than recreational and dependent cocaine users. Furthermore, a significant 
interaction (p<0.05) was found for group*emotional support/strain. 
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4.4.6 Correlation analyses 
Social network size was significantly correlated with test outcomes on the MET, MASC, and 
RMET, indicating that impaired social cognition goes along with worse real-life social 
functioning. Moreover, amount of criminal offences were correlated with the MET IEE score 
reflecting a negative relationship between emotional empathy and adherence to social norms. 
As expected, the scores on the antisocial and narcissistic PD scales were significantly 
correlated with emotional empathy. Interestingly, MET emotional empathy scores and MASC 
were largely independent from each other, while MET cognitive empathy and MASC were 
interrelated and both associated with RMET performance (Table 3), indicating that they all 
share a common cognitive component (e.g., emotion recognition), whereas these more 
cognitive scores and the emotional empathy measures are largely distinct functions. 
Furthermore, the MASC total errors were significantly correlated with cumulative cocaine use 
(ln-transformed), duration of cocaine use, and cocaine/norcocaine in the hair toxicology, 
Finally, social network size was negatively correlated with duration and amount of cocaine use 
(Table 4).  
 














Cocaine       
  grams/week       
  years of use 0.25  -0.30    
  cumulative dose (grams) 0.24  -0.25 0.25 0.24  
  hair sample (pg/mg)       
    COC 0.20      
    NOC 0.22      
Cannabis       
  grams/week      0.30 
  cumulative dose (grams)      0.23 
MDMA       
  pills/week  -0.23     
  cumulative dose (tablets)  -0.28     
Alcohol       
  grams/week     0.21  
Nicotine       
  years of use 0.22  -0.27    
Cocaine craving (CCQ)    0.32 0.23 0.20 
Correlations are calculated for cocaine users only, correlations with p<0.01 are shown in bold, correlations with p>0.05 are not 
shown 
Only measures with significant correlations are shown 
ADHD-SR, ADHD Self-Rating scale; BDI, Beck Depression Inventory;  SCID, Structured Clinical Interview for DSM-IV Disorders;  
SNQ, Social Network Questionnaire;  MASC, Movie for the Assessment of Social Cognition;  
RMET, Reading the Mind in the Eyes Test; CCQ, Cocaine Craving Questionnaire. 






The present study demonstrates that recreational and dependent use of cocaine is associated 
with impairments in specific empathy and mentalizing abilities, which interfere with real-life 
social functioning. Comprehensive psychiatric diagnostics and hair toxicology allowed the 
analysis of as pure as possible cocaine users with little psychiatric comorbidities. Compared to 
stimulant-naïve control persons, these cocaine users showed less emotional empathy, whereas 
cognitive empathy and emotion recognition was not altered. Only dependent users 
additionally displayed impaired mentalizing functions in the MASC that were correlated with 
higher cocaine intake. Moreover, both cocaine user groups reported a smaller social network 
than controls and this real-life indicator of social functioning was significantly correlated with 
several social cognition measures and amount and duration of cocaine use. In addition, also 
the number of committed criminal offences was associated with emotional empathy. Taken 
together, this is, to our knowledge, the first study demonstrating relevant emotional empathy 
and mentalizing impairment in cocaine users affecting real-life social behavior. 
 
The emotional empathy deficits shown here are in line with previous studies reporting 
difficulties in the emotion regulation subscale of the Mayer-Salovey-Caruso-Emotional-
Intelligence-Test in DCU (Fox et al., 2007; 2011). Importantly, decreased emotional empathy 
but intact cognitive empathy was previously reported also in patients with narcissistic PD 
(Ritter et al., 2011), whereas patients with autism displayed the reversed pattern (Dziobek et 
al., 2008; Gleichgerrcht et al., 2012). However, narcissistic symptoms, often comorbid with 
cocaine use as also shown here, cannot alone explain the emotional empathy deficits, as 
statistical control for these symptoms did not change the results. Additionally, narcissistic 
symptoms were not very pronounced in our sample in comparison to earlier studies, probably 
due to the strict exclusion criteria regarding psychiatric comorbidities (Ritter et al., 2011). 
Finally, our finding that cocaine users do not differ from controls in their performance on the 
RMET is also in line with Kemmis et al.(2007), who reported no differences on the RMET score 
between controls, occasional, and regular cocaine users as well.  
 
The MASC is a test to sensitively detect subtle deficits in mentalizing abilities in contrast to 
other less ecologically valid ToM tests (Dziobek et al., 2006). Here, DCU performed worse than 
controls, while RCU did not show any disturbance. DCU made more errors with regard to 




‘overmentalizing’ (overinterpretive perspective-taking). These results suggest that a subtle 
deficit in mental perspective-taking may arise from unusual compensation strategies, rather 
than the loss of cognitive empathy and ToM abilities per se, as they did not make more ‘no-
ToM’ or ‘insufficient ToM’ errors in the MASC (Sharp et al., 2011). Thus, dependent cocaine 
users probably try to take the perspective of others but over-interpret social signs. A previous 
fMRI study showed that the MASC engages the MPFC (Wolf et al., 2010), an area associated 
with the integration of social information (Van Overwalle, 2009), amongst other regions 
related to social cognition. As alterations in this brain region were repeatedly reported for 
cocaine users (Bolla et al., 2004; Ersche et al., 2011; Volkow et al., 1992), it is likely that subtle 
deficits in mentalizing are associated with MPFC alterations. Therefore, mainly the integration 
of social information – which is highly necessary to solve the multimodal MASC – might be 
challenging for dependent users. Furthermore, difficulties in mentalizing were associated with 
duration of cocaine use, cumulated cocaine use, and cocaine and norcocaine in the hair, 
suggesting that problems in mental perspective-taking might be partially cocaine-induced. On 
the other hand, mentalizing deficits may also predispose addictive cocaine use in particular as 
only dependent individuals showed these deficits.  
 
Cognitive and affective aspects of empathy are behaviorally distinguishable and rely on 
dissociable, but overlapping, brain networks. In functional imaging studies, emotional empathy 
engages the ventral striatum, the amygdala, the ACC, the OFC, and the anterior insula (Abu-
Akel and Shamay-Tsoory, 2011; Bernhardt and Singer, 2012) ,whereas cognitive empathy 
depends on the MPFC and the superior temporal gyrus (Vollm et al., 2006). Addicted cocaine 
users have been reported to show alterations in the ventral striatum, as well as the MPFC, 
ACC, and OFC (Bolla et al., 2004; Ersche et al., 2011; Kuhar and Pilotte, 1996; Makris et al., 
2008; Volkow et al., 1992), and these alterations might be associated with our current finding 
of impaired empathy. As emotional empathy is already impaired in recreational users, changes 
in the relevant brain regions (e.g., ventral striatum, OFC, insula), might be more strongly 
related to cocaine use than changes in areas associated with cognitive ToM (e.g., MPFC). As 
these regions are also involved in social reward processing (Katsyri et al., 2012) this would 
support the hypothesis that neuroadaptations in brain reward systems make drug users more 
responsive to the abused drug and also reduce sensitivity to non-drug reinforcers such as 
social interaction (Volkow et al., 2011). This might have a negative impact on general social 
competence and might explain why social consequences such as imprisonment or familial 
problems may fail to detain drug addicted people from using the drug (Volkow et al., 2011). 




Most importantly, our data suggest a relationship between test outcomes and real-life social 
functioning: Participants showing more empathy and better mentalizing abilities had a larger 
social network. In addition, social network size was correlated with duration and amount of 
cocaine use. This implies that cocaine use and the associated deficits in social cognition may 
have consequences in real life, such as fewer social contacts and less emotional support. 
Alternatively, a smaller social network might reduce opportunities to adequately learn and 
practice social abilities, leading to impairments in social cognition and an increase in cocaine 
use. However, longitudinal studies are needed to disclose causality. Additionally, DCU 
committed more criminal offences than controls and the number of criminal offences was 
correlated with social cognition measures. These relationships are especially important, as 
real-life social behavior and social environment are important factors in onset and therapy of 
drug use (Ramirez et al., 2012; Shortt et al., 2007). Therefore, therapeutic and prevention 
approaches focusing on the improvement of social skills and involving the social environment 
should be intensified to improve the impact of treatment strategies against cocaine addiction.  
 
Furthermore, the age in which cocaine use starts seems to influence emotional empathy and 
the number of social contacts, with users who began using cocaine before the age 18 showing 
less empathy than controls. Since we corrected the analyses for cumulated cocaine use, this 
finding is unlikely to be influenced by longer cocaine use in the early onset group. It is also in 
line with previous studies, reporting an association between earlier onset of cocaine 
dependence and elevated motor impulsivity and therefore identifying an early onset of use as 
particularly dangerous (Prisciandaro et al., 2012). Early onset of drug use may be particularly 
harmful, because structural, neurochemical, and functional brain development continues 
during adolescence, which is therefore a period in which the system is highly vulnerable to 
toxic influences (Crone and Dahl, 2012; Jager and Ramsey, 2008). Moreover, puberty is a 
critical time period, when complex social-cognitive skills such as mentalizing evolve and social-
affective skills such as empathy advance (Crone and Dahl, 2012). Alternatively, social 
impairments may have preceded drug use and possibly represent a vulnerability to start using 
drugs. Furthermore, due to their illegal drug use, cocaine users may experience less social 
support and possibilities to acquire and train social abilities. 
 
One limitation of our study is the lack of an objective measure of the duration of abstinence 
beyond urine toxicology. Thus, we were unable to investigate the true effect of abstinence 




duration on empathy and ToM. However, it would have been nearly impossible to control for 
abstinence in our ambulant and voluntary study setting. 
 
In sum, our study provides first evidence that dependent and already also recreational cocaine 
users show deficits in emotional empathy, whereas only dependent users additionally show 
subtle impairments in cognitive empathy and mentalizing. These results suggest that cocaine 
users are less emotionally responsive to other people's emotional state and less able to mirror 
emotions compared to healthy controls. Empathy is crucial to our emotional and social lives 
(Bernhardt and Singer, 2012) and therefore, these deficits could account for antisocial 
behavior, especially as social cognition impairments are related to real-life social behavior such 
as a smaller social network and more criminal offences. The characterization of social cognition 
abilities in cocaine users is crucial for the development of effective prevention and treatment 
strategies, as social cognition predicts treatment success in psychiatric disorders (Couture et 
al., 2006; Homer et al., 2008). Furthermore, it should be considered that treatment 
approaches requiring strong emotional empathy may not be particularly effective in stimulant 
users. Thus, treatment success might benefit from trainings designed to improve social 
cognition and empathy, resembling those designed for schizophrenia patients (Lahera et al., 
2012; Rus-Calafell et al., 2012). Finally, prevention strategies should be intensified towards 
delaying the onset of cocaine use, as a young age of onset is associated with greater deficits in 
empathy and real-life social behavior.  
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4.10 Supplementary material 
 
Methods 1: Recruitment and selection  
Subjects were recruited by means of advertisements in local newspapers, drug prevention and 
treatment centers, psychiatric hospitals, online media, and by word of mouth. Participants 
were considered eligible for the study if they were aged between 18 and 60 years and had 
sufficient German language skills. Eight-hundred-four potential participants completed an 
initial telephone screening, whereof 240 subjects participated in the study. Fourty-six 
participants had to be excluded afterwards because of hair analyses revealing illegal drug use 
not declared in the interviews (e.g., opioids, excessive MDMA use) or lack of cocaine use. 
Further 26 participants were excluded due to matching reasons (age, IQ, education, and 
smoking) between groups (17 controls, 9 cocaine users). Therefore, 168 datasets were 
included in the analysis. Hair samples were provided by 165 subjects, as hair analysis was not 
possible by reason of an insufficient amount of hair for three participants (2 controls, 1 
recreational cocaine user). Urine toxicology was not possible for one recreational cocaine user. 
 
Methods 2: Urine and hair toxicologies  
Urine toxicology analyses comprised the compounds/substances: tetrahydrocannabinol, 
cocaine, amphetamines, benzodiazepines, opioids, and methadone and were assessed by a 
semi-quantitative enzyme multiplied immunoassay method using a Dimension RXL Max 
(Siemens, Erlangen, Germany).  
To characterize drug use over the last six months objectively, hair samples were collected and 
analyzed with liquid chromatography-tandem mass spectrometry (LC-MS/MS). If participants’ 
hair was long enough, one sample of six cm hair (from the scalp) was taken and subsequently 
divided into two subsamples of three cm length. The following compounds were assessed: 
cocaine, benzoylecgonine, ethylcocaine, norcocaine, amphetamine, methamphetamine, 
MDMA, 3,4-methylenedioxy-N-ethylamphetamine (MDEA), 3,4-methylenedioxyamphetamine 
(MDA), morphine, codeine, methadone EDDP (2-ethylidene-1,5-dimethyl-3,3-
diphenylpyrrolidine; primary methadone metabolite), tramadol, and methylphenidate.  
For our routine protocol for drugs of abuse analysis, a three step washing procedure with 
water (2 minutes shaking, 15 ml), acetone (2 min., 10 ml) and finally hexane (2 min., 10 ml) of 




hair was performed. Then the hair samples were dried at ambient temperatures, cut into small 
snippets and extracted in two steps, first with methanol (5 ml, 16 hours, ultrasonication) and a 
second step with 3 ml MeOH acidified with 50 μL hydrochloric acid 33% (3 hours, 
ultrasonication). The extracts were dried and the residue reconstituted with 50 μL MeOH and 
500 μL 0.2 mM ammonium formate (analytical grade) in water. As internal standards 
deuterated standards of the following compounds were used, added as mixture of the 
following compounds: cocaine-d3, benzoylecgonine-d3, ethylcocaine-d3, morphine-d3, MAM-
d3, codeine-d3, dihydrocodeine-d3, amphetamine-d6, methamphetamine-d9, MDMA-d5, 
MDEA-d6, MDA-d5, methadone-d9, EDDP-d3, methylphenidate-d9, tramadol-d3, oxycodone-
d3, and ephedrine-d3. All deuterated standards were from ReseaChem (Burgdorf, 
Switzerland), the solvents for washing and extraction were of analysis grade and obtained 
from Merck (Darmstadt, Germany); LC-solvents were of high-performance LC grade and were 
obtained from Sigma Aldrich (Buchs, Switzerland).  
The LC-MS/MS apparatus was an ABSciex QTrap 3200 (Analyst software Version 1.5, Turbo V 
ion source operated in the ESI mode, gas 1, nitrogen (50 psi); gas 2, nitrogen (60 psi); ion spray 
voltage, 3500V; ion source temperature, 450°C; curtain gas, nitrogen (20 psi) collision gas, 
medium), with a Shimadzu Prominence LC-system (Shimadzu CBM 20 A controller, two 
Shimadzu LC 20 AD pumps including a degasser, a Shimadzu SIL 20 AC autosampler and a 
Shimadzu CTO 20 AC column oven, Shimadzu, Duisburg, Germany). Gradient elution was 
performed on a separation column (Synergi 4μ POLAR-RP 80A, 150x2.0 with a POLAR-RP 4x2.0 
Security Guard Cartridge, (Phenomenex, Aschaffenburg, Germany). The mobile phase 
consisted of 1 mM ammonium formate buffer adjusted to pH 3.5 with formic acid (eluent A) 
and acetonitrile containing 1 mM ammonium formate and 1 mM formic acid (eluent B). The 
analysis was performed in multiple reaction monitoring mode with two transitions per analyte 
and one transition for each deuterated internal standard, respectively. 
 
Methods 3: Task details  
MET: The task is designed to differentiate two facets of empathy: cognitive (CE) and emotional 
empathy (EE). EE can be sub-divided in explicit emotional empathy (empathic concern, EEE) 
and implicit emotional empathy (arousal, IEE), where IEE may be less prone to social 
desirability. CE, IEE, and EEE are assessed for each photograph in a pseudorandomized order. 
Correct responses in the CE condition are scored as one point, therefore a sum score for CE is 




computed, whereas average rating scores are calculated for IEE and EEE. The MET has been 
shown to detect deficits in CE in patients with autism spectrum disorders (ASD) (Dziobek et al. , 
2008), and deficits in EE in patients with narcissistic personality disorder (Ritter et al. , 2011). 
Internal consistency of the MET scales ranged from Cronbach’s α=0.71 to α=0.92 (Dziobek et 
al. , 2008). 
MASC: The MASC has been shown to reliably detect even subtle mindreading difficulties 
amongst others in healthy individuals of normal IQ (Smeets et al. , 2009, Hassenstab et al. , 
2007), and patients with schizophrenia (Montag et al. , 2011), borderline personality disorder 
(Preissler et al. , 2010), and ASD(Dziobek et al. , 2006). It has been reported to be more 
sensitive than other mindreading tests (strange stories task (Happe, 1994), RMET (Baron-
Cohen et al. , 2001), basic emotion recognition (Ekman and Friesen, 1971)), due to the video-
based and realistic nature of the stimuli (Dziobek et al. , 2006). The test has a good internal 
consistency with Cronbach’s α=0.84 (Dziobek et al. , 2006). 
RMET: The photographs can be separated according to the valence of the depicted emotion 













Figure 1.  Mean explicit and implicit emotional empathy ratings (A) and mean correct answers on the 
cognitive empathy scale (B) of the 
craving, cocaine users were divided into users with low (CCQ<16, n=41) and high craving 
(CCQ≥16, n=59) by median split. A MANCOVA (corrected for age and years of education) 
comparing cocaine users with high craving , low 
significant main effect for group (F(6,324)=1.92, p<0.08). Error bars refer to SEM.
 
 
multifaceted empathy test (MET). To test the influence of 









Figure 2.  Mean explicit and implicit emotional empathy ratings of the 
(MET). A MANCOVA (corrected for age and years of education) for ADHD subgroups (cocaine 
users fulfilling DSM
(n=78) vs. controls (n=68) revealed a significant main effect for group (F(6,324
with groups differing in EEE (F(2,163)=5.68, p<0.01) and IEE (F(2,163)=4.91, p<0.01). Controls 
showed more empathy than both, cocaine users with and without ADHD, on the EEE (p<0.03, 
d=0.40-0.68) and IEE scale (p<0.04, d=0.42
between cocaine users with and without ADHD (p>0.55, d=0.16
were found for CE (F(2,163)=2.53, p>0.08). Cocaine use parameters did not differ between 
cocaine users with and without ADHD (all p>.24).
significant difference between groups (p<.05).
 
 
multifaceted empathy test 
-IV criteria for ADHD (n=22) vs. cocaine users not fulfilling these criteria 
-0.59). No significant differences were found 
-0.27). No group differences 











Figure 3.  Mean explicit and implicit emotional empathy ratings of the
(MET). To test the influence of depressive symptoms, the user groups 
a predefined depression criterion (low/high, BDI<11/BDI
and years of education) for depressive subgroups (low: n=69, high: n=31) comparing them 
with controls (n=68) revealed a significant main effec
groups differing in EEE (F(2,163)=5.04, p<0.01) and IEE (F(2,163)=5.30, p<0.01). Controls 
differed from both, cocaine users with a high and low BDI score on the EEE (p<0.03, d=0.43
0.53) and the IEE scale (p<0.05, d
cocaine users with low and high BDI scores (p>0.61, d=0.22
found for CE (F(2,163)=0.62, p>0.54). Cocaine use parameters did not differ between cocaine 
users low and high BDI scores (all p>.05). Error bars refer to SEM. * indicates significant 
difference between groups (p<.05).
 
 multifaceted empathy test 
≥11). A MANCOVA (corrected for age 
t for group (F(6,324)=2.28, p<0.04) with 
=0.39-0.62). No significant difference was found between 











Figure 4. Mean of total errors on the movie for the assessment of social cognition (MASC).
the influence of ADHD, cocaine users we
for ADHD (n=22) and cocaine users not fulfilling these criteria (n=78) and compared with 
controls (n=68). An ANCOVA corrected for age and years of education revealed a significant 
main effect for gro
with ADHD performing significantly worse than controls (p<0.01, d=0.72) and cocaine users 
without ADHD (p<0.02, d=0.63). Cocaine users without ADHD did not differ from controls 
(p>0.98, d=0.09). Error bars refer to SEM. * indicates significant difference between groups 
(p<.05). 
 
re divided into cocaine users fulfilling DSM










Figure 5. Mean of total contacts assessed with the social network questionnaire (SNQ)
with an age of onset (AoO) of coca
Cocaine users with an AoO




ine use ≤18 (n=24) and >18 (n=65), and controls (n=65). 
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The studies presented in Chapters 2 to 4 were conducted to investigate neural, behavioral and 
social changes occurring in different stages of drug addiction. The following paragraphs aim to 
discuss the results of the presented studies in greater detail (Chapters 5.1-5.3), disclose their 
implications for the addiction models introduced in Chapter 1.1 and for clinical practice such as 
prevention, treatment and after-care programs (Chapters 5.4 and 5.5), and finally future 
research questions are discussed (Chapter 5.6).  
 
5.1 Sustained incentive value of heroin cues 
 
Drug dependence, and opiate dependence in particular, has been associated with high relapse 
rates after treatment (Hser et al., 2001; O'Brien, 1997). According to the drug addiction model 
proposed by Volkow et al. (2011a; 2003; 2011b) and theories of addiction memory (Berke and 
Hyman, 2000; Hyman and Malenka, 2001; Hyman et al., 2006; Kelley, 2004; Robbins and 
Everitt, 2002; White, 1996) this vulnerability to relapse might be caused by neuroadaptive 
effects in memory and motivational networks of the brain. Drug related cues are turned into 
powerful incentives and may contribute to compulsive drug taking and relapses (Robinson and 
Berridge, 2000). These theories have been corroborated by studies showing that drug cues are 
processed as appetitive in nicotine and alcohol dependent persons (Dempsey et al., 2007; 
Grüsser et al., 2002; Mucha et al., 2000; Rehme et al., 2009). However, it has not been 
investigated, if heroin-related cues keep their appetitive effects after detoxification and long-
term abstinence. This might disclose if changes in memory and reward systems of the brain are 
lasting even after longer periods of abstinence, and might explain the enduring susceptibility 
for relapse. Therefore, these issues have been addressed in the experiment presented in 
Chapter 2 of this thesis. 
The analysis of the data presented in Chapter 2 supports incentive theories of drug addiction. 
We found that heroin-associated cues are processed as appetitive in current heroin users, as 
heroin-dependent participants in contrast to controls showed a significant reduction in startle 
amplitude when viewing heroin related cues in comparison with neutral pictures. These results 
obtained with the implicit measure of affective startle modulation (see Chapter 1.3.1) are 
supported by explicit ratings of valence. This is in line with previous findings of increased 





activations in reward-related brain areas when heroin users are exposed to heroin-related 
cues (Wang et al., 2011). The incentive effect of heroin-related cues also persists after 
detoxification therapy in our sample. In alcohol addiction appetitive effects of drug cues have 
also been measured during detoxification and early abstinence (Grüsser et al., 2002), 
indicating that alterations in the processing of drug cues outlast therapy at least in alcohol and 
heroin users. Craving ratings in response to heroin cues also did not change after therapy, 
proposing a protracted abstinence syndrome (Fatseas et al., 2011; Shi et al., 2007). These 
strong explicit and implicit appetitive effects of drug cues may increase the vulnerability for 
relapse after detoxification. 
Importantly, the implicit appetitive effects of heroin-related cues can still be found in heroin 
users after at least one year of abstinence, suggesting that neuroadaptations proposed by 
addiction models (e.g., Hyman, 2005; Robinson and Berridge, 2000; Volkow et al., 2003; White, 
1996) are persistent over longer periods of abstinence in heroin users. This is in line with a 
previous study , reporting a persistent decrease of DA transporters in the striatum of long-
term abstinent heroin users (Shi et al., 2008). Therefore, long-lasting, or maybe even 
permantent, alterations in the DA system might account for the vulnerability to relapse even 
after prolonged abstinence (Kalivas and Volkow, 2005; Kelley, 2004).  
However, the analysis of explicit ratings of valence and craving showed that former heroin 
users do not report more craving or pleasure when viewing heroin related cues than controls. 
As alterations in neural pathways seem to be long-lasting and can still be measured in the 
implicit reaction to drug cues, this suggests that top-down controlled processes might support 
the successful abstinence reported by these former heroin users. Therefore, cognitive 
strategies of devaluating drug cues, which have previously been shown to increase abstinence 
in smokers (Rose, 2006), may be a promising addition to relapse prevention programs in 
heroin users. Furthermore, after-treatment programs should be long-lasting and may still be 
valuable after years of abstinence. 
  





5.2 Increased sensorimotor gating in recreational and dependent cocaine 
users  
 
In Chapter 2 we showed that neuroadaptations related to drug use can be long-lasting. 
However, it is not known if already recreational drug use is associated with alterations in 
neurotransmission. PPI of the acoustic startle reflex has been shown to capture changes in 
catecholamine neurotransmission (Braff et al., 2001; Zhang et al., 2000): for example 
antipsychotic medication has been shown to normalize PPI in schizophrenia patients (Csomor 
et al., 2009; Kumari et al., 2002; Quednow et al., 2006). Reward related areas which have been 
shown to be altered in dependent cocaine users (Ersche et al., 2011; Volkow et al., 1993; 
Volkow et al., 1997b) and the CSPP circuits controlling PPI (Koch, 1999; Swerdlow et al., 1999) 
overlap in the ventral striatum, therefore we assumed that PPI may be a promising and non-
invasive measure to capture alterations in neurotransmission associated with cocaine use (see 
Chapter 1.3.2). However, studies on lasting effects of cocaine use on PPI are scarce. Therefore, 
in the experiment presented in Chapter 3 of this thesis, it was investigated if changes in 
neurotransmission in dependent cocaine users can be captured with PPI and whether already 
recreational cocaine users show alterations in PPI.  
The analysis of PPI data revealed that PPI is robustly increased in recreational and dependent 
cocaine users with amount and duration of cocaine use being positively correlated with PPI 
increase. Firstly, these results suggest that PPI might indeed be sensitive to alterations in 
catecholamine systems of cocaine users. Secondly, already recreational cocaine users show 
modifications of PPI and therefore presumably of catecholamine neurotransmission. This 
interpretation is supported by our finding that cocaine users with positive cocaine urine 
samples displayed almost normal PPI levels, given that recent cocaine use increases DA and NE 
levels (Hutchison and Swift, 1999; Martinez et al., 1999; Ritz et al., 1990). An existing deficit in 
catecholamine levels may therefore be balanced by the use of cocaine. This is in line with a 
previous study reporting altered blue-yellow color vision in recreational and dependent 
cocaine users (Hulka et al., 2012) and suggesting changes of the DA system already at a non-
dependent level of cocaine use.  





Furthermore, the influence of craving and ADHD symptoms on PPI was examined, since both, 
ADHD and craving, have been associated with dysregulated DA and NE functioning (Del Campo 
et al., 2011; Erb, 2010; Howells et al., 2012; Sofuoglu and Sewell, 2009; Volkow et al., 1997b; 
Volkow et al., 2009). ADHD symptoms and craving increased PPI levels in cocaine users, even 
when the influence of amount and duration of cocaine use was controlled for. Previous studies 
did not find alterations or only slight nonsignificant increases in PPI in nontreated adults with 
ADHD symptoms (Feifel et al., 2009; Hanlon et al., 2009; Holstein et al., 2012). These studies 
might have been underpowered, or the PPI enhancement in cocaine users with ADHD 
symptoms might be a result of an interaction of cocaine use and ADHD pathophysiology. 
Presumably, cocaine users with ADHD symptoms experience more severe craving, which is 
reflected by the strongest increase in PPI. This may be a result of a predisposed dysfunctional 
catecholamine system, which could be more vulnerable for cocaine-induced neurochemical 
plasticity. Therefore, ADHD could be a critical risk factor for stronger cocaine-induced neural 
alterations and therefore maybe even a faster transition to an addictive state of cocaine use 
and a greater risk for relapse. Furthermore, while cocaine users with ADHD symptoms and high 
craving showed the strongest increase in PPI levels, PPI was still significantly enhanced in 
cocaine users without ADHD but high craving. This suggests that PPI may subserve as a suitable 
objective measure to capture acute stimulant craving.  
  





5.3 Impaired emotional empathy in cocaine users is related to social 
network deficits 
 
In the experiment described in Chapter 3 we presented that dependent and already 
recreational cocaine users probably show alterations in neurotransmission. These 
neuroadaptations presumably also impact brain areas related to social reward (Abu-Akel and 
Shamay-Tsoory, 2011; Fan et al., 2012; Gallagher and Frith, 2003; Krach et al., 2010). 
Accordingly, Volkow et al. (2011a) proposed that social behavior might be influenced, as 
sensitivity to social reinforcers is reduced, while the value of the drug of choice is increased. 
Furthermore, cocaine-related dysfunctions in brain areas associated with social cognition 
might have a negative impact on social competence in general. Even though social cognition 
may have a strong impact the on onset of drug use and treatment success (Homer et al., 2008; 
Ramirez et al., 2012), studies on social cognition in cocaine users have been lacking. The study 
presented in Chapter 4 therefore investigates empathy, mentalizing, and real life social 
behavior in recreational and dependent cocaine users.  
As reported in Chapter 4, we could demonstrate for the first time that cocaine users display 
emotional empathy and mentalizing deficits, which are also reflected in real-life social 
behavior. Recreational and dependent cocaine users show impairments in emotional empathy, 
whereas cognitive empathy is not affected. Dependent cocaine users additionally performed 
worse in a mentalizing task (Movie for the Assessment of Social Cognition, MASC; see Chapter 
1.3.3). The MASC has been shown to rely on the MPFC (Wolf et al., 2010). This region has 
frequently been shown to be altered in cocaine users (Bolla et al., 2004; Ersche et al., 2011; 
Volkow et al., 1992), therefore deficits in mentalizing in dependent cocaine users may be 
associated with dysfunctions of the MPFC. As this area engages in the integration of social 
information (Van Overwalle, 2009), this process might be particularly difficult for dependent 
cocaine users. These deficits seem to be at least partly drug induced, as worse performance in 
mentalizing was correlated with higher cocaine intake. However, it might also be possible that 
social cognition deficits represent a predisposition for more intense cocaine use. 
Since only emotional empathy is affected in cocaine users and cognitive empathy is spared, 
and already recreational users show these deficits, alterations in brain areas related to 





emotional empathy (e.g. ventral striatum, OFC; insula (Abu-Akel and Shamay-Tsoory, 2011; 
Bernhardt and Singer, 2012; Walter, 2012)) might be more strongly associated with cocaine 
abuse than changes in areas engaged in cognitive empathy (e.g. MPFC (Vollm et al., 2006)). 
Furthermore, these data suggest that striatal and orbitofrontal areas are already impaired at 
an early stage of drug use, while dysfunctions of the MPFC occur only later, at a dependent 
level of cocaine use. Striatal and frontal areas are also related to social reward processing 
(Katsyri et al., 2012). This corroborates the model by Volkow et al. (2011a), which suggests 
that alterations in the reward system make drug users more responsive to the abused drug, 
but less sensitive to social rewards.  
Empathy is fundamental to our emotional lives and social interactions (Walter, 2012). Our data 
suggest that deficits in empathy measured with the tests of social cognition used in Chapter 4 
are related to real-life social behavior and functioning. Cocaine users with deficits in empathy 
and mentalizing had a smaller social network and committed more criminal offences. As social 
network size was associated with duration and amount of cocaine use, this corroborates the 
hypothesis that cocaine use leads to neuroadaptations and deficits in social cognition, which 
has consequences in real-life such as a smaller social network. However, a smaller social 
network might also limit the possibility to learn social abilities leading to the measured deficits 
and increase the vulnerability to drug use. This is plausible, since the acute effects of cocaine 
use include enhanced self-esteem and self-confidence in social situations (Dackis and Gold, 
1985) and might therefore make cocaine interesting for people with problems in social 
interaction.  
Moreover, we showed that persons who start using cocaine before the age of 18 displayed 
more deficits in empathy. This is in line with previous studies showing that an early onset of 
drug use is particularly harmful and for example leads to greater IQ declines and elevated 
impulsivity (Meier et al., 2012; Prisciandaro et al., 2012). This may be explained by the ongoing 
brain maturation during adolescence and the continuative development of social skills during 
this period (Crone and Dahl, 2012; Jager and Ramsey, 2008). Therefore, prevention strategies 









5.4 Implications for models of addiction and the understanding of 
substance use disorders 
 
In sum, these results corroborate different aspects of the addiction model proposed by Volkow 
et al. (2011a; 2003; 2011b) and models of addiction memory (Berke and Hyman, 2000; Hyman 
and Malenka, 2001; Hyman et al., 2006; Kelley, 2004; Robbins and Everitt, 2002; White, 1996) 
(see Chapter 1.1). The results of the experiments reported in Chapter 2 confirm the close 
relationship between reward-related learning, memory, and addiction, which has been 
proposed by theories of drug addiction and addiction memory. Presumably by repeated 
association of drug cues with the rewarding effect of the drug itself, neuroadaptations result in 
a hypersensitive DA system in response to drug-associated stimuli (Kelley, 2004; Robinson and 
Berridge, 1993). Volkow et al. (2011a; 2003; 2011b) also proposed that memory circuits are 
overactive in addicted drug users and assign a higher value to the experience of the drug 
effects than in non-addicted persons. This contributes to a vicious circle of compulsive drug 
taking. Our results confirm the role of drug cues as appetitive stimuli that induce craving and 
may contribute to the continuing use of the drug. Memory systems seem to process drug cues 
differently in users of the substance than in controls naïve to the drug. This corroborates that 
drug use exerts an influence on brain systems related to consolidation of experiences. 
Furthermore, we could broaden these models by showing that the altered processing of drug 
cues is sustained after detoxification and even after long-term abstinence. This suggests that 
neuroadaptations in memory systems induced by drug use are long-lasting and may contribute 
to the vulnerability to relapse even after years of abstinence (O'Brien, 1997). Additionally, we 
found that despite the implicit reaction to drug cues, the explicit cognitive evaluation of the 
valence of drug cues returns to normal levels after long-term abstinence. This might indicate, 
that the control circuit, which is suggested to be weakened in addiction (Volkow et al., 2011a; 
2003; 2011b), recovers earlier in abstinence and allows to inhibit drug-cue driven approach 
behavior and therefore to maintain abstinence.  
Furthermore, addiction models described in Chapter 1.1 only cover alterations in a drug 
dependent state, even though it is important for prevention and therapy to know if already 
recreational drug use holds the risk of neurochemical alterations. In Chapter 3 we could show 
that recreational cocaine use is likely associated with altered catecholamine functioning. 





Moreover, we demonstrated that further factors such as ADHD symptoms and craving in may 
contribute to neurochemical plasticity induced by drugs. As described in 5.2 cocaine users with 
ADHD and craving symptoms showed the greatest increase in PPI, suggesting that cocaine 
users with ADHD symptoms might also experience more craving. A dysfunctional 
catecholamine system has been shown to be associated with ADHD symptoms (Del Campo et 
al., 2011; Howells et al., 2012), thus cocaine users with ADHD might be at risk for stronger 
cocaine-induced alterations of the brain. This might result in a faster transition to an addictive 
state and a higher risk for relapse. Therefore, further influencing factors, such as ADHD and 
potential psychopathology, should be considered in models of addiction. Moreover, we 
demonstrated that already recreational cocaine users show electrophysiological and 
behavioral alterations. Therefore, addiction models should also embed recreational drug use, 
as dysfunctions in catecholamine neurotransmission have been associated with craving and 
loss of control over drug intake (Martinez et al., 2007; Volkow et al., 1997a; 1997b), and 
impaired social cognition may increase the vulnerability for drug taking and decrease 
treatment success (Couture et al., 2006; Homer et al., 2008; Volkow et al., 2011a). Addiction 
may be a dimensional construct, with neuronal and behavioral consequences already at a non-
dependent state of drug use.  
The data presented in Chapter 4 support the assumption that substance use is associated with 
deficits in social behavior (Volkow et al., 2011a). Dependent and recreational drug users show 
impairments in emotional empathy, which are related to a real-life social functioning such as a 
smaller network size. These data corroborate models proposing that drug use influences brain 
areas which are engaged in social cognition (e.g., Hyman et al., 2006; Kalivas and Volkow, 
2005; Volkow et al., 2011a). Furthermore, they support the hypothesis that neuroadaptations 
in brain reward systems increase the perceived value of the abused drug but decrease 
responsivity to non-drug reinforcers such as social interaction, which also might render drug 
users insensitive to social consequences such as imprisonment or decline of relationships 
(Volkow et al., 2011a; Volkow et al., 2009). However, in order to be generalized, social 
cognition deficits have to be replicated in users of other drugs.  
 
  





5.5 Implications for clinical practice 
 
The results presented in Chapters 2-4 hold several implications for treatment and prevention 
of substance use disorders. First of all, in Chapter 2 we found that even after long-term 
abstinence heroin users still show enhanced implicit appetitive processing of drug cues, which 
increases the vulnerability for relapse in particular in response to drug-related stimuli. 
Therefore, after detoxificantion and even after longer periods of abstinence the contact with 
dug related cues and environments should be very careful. Drug paraphernalia as well as 
places and people associated with drug use should be either avoided or cognitively devaluated 
if possible. Trainings of cognitive strategies to reduce the motivational impact of drug cues 
should be applied during and after detoxification therapy. These strategies have already been 
shown to successfully enhance abstinence in smokers (Rose, 2006). After detoxification, 
former heroin users should be motivated to take part in long-lasting relapse prevention 
programs (Min et al., 2011), as explicit and implicit valence and craving ratings in response to 
drug cues did not change with detoxification. Long-term support after treatment should be 
ensured, as sensitization of neural pathways seems to be persistent even after prolonged 
abstinence. Furthermore, education about this sustained vulnerability to relapse in response 
to drug cues ought to be part of relapse prevention programs.  
Secondly, ADHD symptoms have been identified as a risk factor for increased craving and 
maybe for enhanced vulnerability to cocaine-induced plasticity. Consequently, cocaine users 
with ADHD symptoms may be at greater risk to undergo the transition from recreational to 
addicted use and for relapse. This should be implemented and reported in prevention 
programs. Furthermore, ADHD symptoms should be considered in therapy. It has to be 
evaluated if cocaine addicted patients with ADHD might need different pharmacological and 
therapeutic interventions than cocaine users without ADHD symptoms.  
Thirdly, our data suggest that already recreational cocaine users are at risk of neurochemical 
alterations. These changes are associated with craving and loss of control over drug use 
(Martinez et al., 2007; Volkow et al., 1997a; 1997b), and deficits in social cognition (Chapter 4), 
and therefore possibly the devaluation of social stimuli and the loss of social contacts and 
relationships (Volkow et al., 2011a). Thus, recreational drug use has to be taken seriously and 
education about these risks should be offered in prevention programs. Interventions and 





education in settings of recreational drug use ought to be intensified and may be implemented 
already at the level of school education. 
Fourthly, the deficits in empathy and mentalizing should be considered in therapy and 
prevention approaches as well. Available pharmacological treatments for cocaine addiction are 
currently not sufficiently effective (O'Brien, 2005) and treatment concepts such as cognitive 
behavioral therapy, community reinforcement approach, and contingency management rely 
on the emotional responsiveness and ability to process social reinforcement of the patients 
(Moos, 2007). It should be considered that treatment approaches relying on emotional 
empathy may not be particularly effective in stimulant users. Before these interventions are 
applied, it may be useful to focus on trainings designed to improve social skills, which might 
resemble those designed for schizophrenia patients (Lahera et al., 2012; Rus-Calafell et al., 
2012). Furthermore, for therapy and prevention strategies it should be considered that threats 
such as imprisonment, or family and relationship problems might not have the same deterrent 
effect already in recreational cocaine users.  
Lastly, we could show that an early onset of cocaine use might be particularly harmful, as a 
young age of onset was associated with greater deficits in empathy. Therefore, prevention 
strategies should be implemented at a reasonably early age and should aim at delaying the 
onset of cocaine use as long as possible. 
  







With the studies presented in the experimental part of the thesis, we were able to fill gaps in 
the current knowledge related to the stability of addiction memory, alterations in 
neurotransmission in recreational cocaine users, and social cognition deficits in cocaine users. 
However, some open questions remain, which should be addressed in future studies.  
First of all, the studies presented in Chapter 2 were mainly conducted with male heroin users. 
It has still to be evaluated if the results are generalizable to women. Moreover, it should be 
investigated if trainings to devalue heroin cues are successful in reducing the implicit value and 
in maintaining abstinence. The efficacy of these trainings ought to be evaluated during 
detoxification and during after-care relapse prevention programs. Furthermore, we showed 
that cue reactivity is enhanced in former heroin user who remained abstinent for at least one 
year. However, it is still not known if alterations in memory systems outlast this time period or 
are maybe even permanent, as suggested by some models of addiction (e.g., Kalivas and 
Volkow, 2005; Kelley, 2004). Therefore, former heroin users who were able to maintain 
abstinence for longer time durations have to be investigated. Moreover, since Savvas et al. 
(2012) reported that methadone treatment influences emotional reactivity, it still has to be 
investigated if patients in an opioid-maintainance program show different processing of drug-
related cues than the abstinent heroin users. Finally, our data suggest that the cognitive 
evaluation of the valence of drug cues returns to normal levels after long-term abstinence. This 
might be associated with normal functioning of control circuits. In accordance with addiction 
models (Volkow et al., 2011a; 2003; 2011b), brain areas such as the PFC seem to be able to 
inhibit drug-cue driven approach behavior resulting from still dysfunctional memory circuits. 
This hypothesis should be investigated using imaging methods, to evaluate if certain brain 
areas recover earlier in abstinence and are therefore supportive in maintaining abstinence.  
The studies presented in Chapter 3 and 4, which were conducted with cocaine users, are cross-
sectional studies, therefore we cannot draw any conclusions so far about whether the deficits 
are drug-induced or represent a predisposition and maybe even an increased vulnerability for 
drug use. Therefore, longitudinal analyses, as strived for by our group, are necessary to 
disclose causality, and examine if differences in PPI and therefore neurotransmission may have 
preceded cocaine use. Furthermore, longitudinal studies will offer the possibility to examine if 





social cognition deficits are cocaine induced and have consequences in real-live social behavior 
or whether the smaller social network and lack of support prevented a normal development of 
social cognition abilities and therefore promoted drug use. Additionally, long-term studies will 
also be necessary to evaluate if the alterations in neurotransmission and social cognition 
reported in Chapter 3 and 4 are reversible after the cessation of drug use. 
We did not find a correlation between self-reported cocaine abstinence duration and startle 
reactivity or PPI. However, previous studies have been inconsistent regarding the influence of 
abstinence duration on startle reactivity: Efferen et al. (2000) reported decreased startle 
reactivity in early abstinent cocaine users, whereas Corcoran et al. (2011) only found reduced 
startle magnitude after 40 days of abstinence. In our study, which took place in an ambulant 
setting, we had to rely on self-reported abstinence duration beyond the period that can be 
controlled by urine toxicology. Therefore, further studies are needed to disclose the effect of 
abstinence on startle reactivity. Furthermore, our data suggest that ADHD symptoms might be 
associated with stronger craving and a higher vulnerability to cocaine-induced plasticity. These 
relationships have to be investigated more specifically, especially as drug users with ADHD 
symptoms may represent a clinical subpopulation which might have special needs in therapy 
and relapse prevention. Moreover, as PPI and also the vulnerability to develop substance 
abuse disorders have, at least partly, a genetic basis (Agrawal and Lynskey, 2008; Anokhin et 
al., 2003; Hasenkamp et al., 2010; Quednow et al., 2010), genetic influences on PPI in drug 
users should be investigated.  
Finally, we reported that cocaine users display specific deficits in social cognition which are 
related to real-life social functioning. These data corroborate the model by Volkow et al. 
(2011a) (Chapter 1.1). Social cognition deficits have also been shown in alcohol dependent 
patients (Uekermann et al., 2007) and proposed in methamphetamine users (Homer et al., 
2008). However, to fully generalize this model, social cognition has to be investigated in other 
legal and illegal drugs. Furthermore, our data implicate that brain areas related to emotional 
empathy are more strongly and earlier influenced by cocaine use than areas related to 
cognitive empathy and mentalizing. The application of imaging methods ought to be 
considered to further investigate this hypothesis. Moreover, as reward systems have been 
shown to be impaired in drug users (Goldstein et al., 2007; Jentsch and Taylor, 1999; Volkow et 
al., 2010), the deficits in social cognition may also arise from a different processing of social 





rewards and therefore a reduction in motivation for social interaction. This hypothesis is 
currently being investigated by our group using functional magnetic resonance imaging. More 
precisely, an interactive eye-tracking paradigm is applied to investigate the neural correlates of 
social gaze behavior and joint attention in cocaine users and controls. It has previously been 
reported that self-initiated joint attention is experienced as pleasant and accompanied by an 
increase in neural activity in reward related brain areas in healthy participants. This hedonic 
experience might underlie the human motivation to share experiences (Schilbach et al., 2009). 
We hypothesize that joint attention is processed differently in cocaine users and is not 
associated with the same activations in the reward system as in controls. Furthermore, a 
second paradigm is applied to test the processing of social rewards through social agreement. 
It has been shown that the agreement with two "expert" reviewers on music choice leads to 
increased activity in the ventral striatum (Campbell-Meiklejohn et al., 2012). Again, we expect 
cocaine users to be less rewarded by social agreement and therefore to show less activation in 
reward related brain areas than controls. These results would further corroborate the 
hypothesis that alterations in the reward system of cocaine users lead to altered processing of 
social reward and might explain reduced motivation for social interaction and deficits in social 
behavior in cocaine users.  
Lastly, the application of comprehensive psychiatric diagnostics and hair toxicology has been 
proven to be a successful approach to collect a well-described sample of drug users without 
politoxic drug use patterns. Therefore, the application of methods to quantify drug use over a 
longer time period is strongly encouraged in future studies with drug users. 
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